2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary.

[1]  P. Charron,et al.  External validation of risk factors for malignant ventricular arrhythmias in lamin A/C mutation carriers , 2019, European journal of heart failure.

[2]  S. Viskin,et al.  Long-term flecainide therapy in type 3 long QT syndrome , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[3]  Marmar Vaseghi,et al.  Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias. , 2017, Journal of the American College of Cardiology.

[4]  J. Goldberger,et al.  Sudden Cardiac Arrest Risk Assessment: Population Science and the Individual Risk Mandate , 2017, JAMA cardiology.

[5]  Amit R. Patel,et al.  Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis. , 2017, JACC. Cardiovascular imaging.

[6]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[7]  S. Szymkiewicz,et al.  Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry. , 2017, JACC. Clinical electrophysiology.

[8]  M. Link,et al.  Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management. , 2017, Journal of the American College of Cardiology.

[9]  G. Tomaselli,et al.  Left Ventricular Dysfunction and Conduction Disturbances in Patients With Myotonic Muscular Dystrophy Type I and II , 2017, JAMA cardiology.

[10]  G. Fu,et al.  Characterization of the epicardial substrate for catheter ablation of Brugada syndrome. , 2016, Heart rhythm.

[11]  I. Anand,et al.  Implantable Cardioverter-Defibrillator Use in Patients With Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis. , 2016, JACC. Heart failure.

[12]  M. Ackerman,et al.  Clinical Presentation of Pediatric Patients at Risk for Sudden Cardiac Arrest. , 2016, The Journal of pediatrics.

[13]  T. Trikalinos,et al.  Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine. , 2016, JAMA.

[14]  T. Sakamoto,et al.  Fontan circulation over 30 years. What should we learn from those patients? , 2016, Asian cardiovascular & thoracic annals.

[15]  T. Chao,et al.  Long-Term Outcome of Non-Sustained Ventricular Tachycardia in Structurally Normal Hearts , 2016, PloS one.

[16]  H. Huikuri,et al.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge , 2016, Journal of arrhythmia.

[17]  P. Berne,et al.  Long-Term Trends in Newly Diagnosed Brugada Syndrome: Implications for Risk Stratification. , 2016, Journal of the American College of Cardiology.

[18]  A. Raissadati,et al.  Late Causes of Death After Pediatric Cardiac Surgery: A 60-Year Population-Based Study. , 2016, Journal of the American College of Cardiology.

[19]  P. Leprince,et al.  Implantable cardioverter-defibrillators in end-stage heart failure patients listed for heart transplantation: Results from a large retrospective registry. , 2016, Archives of cardiovascular diseases.

[20]  M. Poetsch,et al.  The role of known variants of KCNQ1, KCNH2, KCNE1, SCN5A, and NOS1AP in water-related deaths , 2016, International Journal of Legal Medicine.

[21]  J. Cho,et al.  Prognosis of Variant Angina Manifesting as Aborted Sudden Cardiac Death. , 2016, Journal of the American College of Cardiology.

[22]  D. Packer,et al.  Mechanism and outcomes of catheter ablation for ventricular tachycardia in adults with repaired congenital heart disease. , 2016, Heart rhythm.

[23]  R. Peinado,et al.  Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study , 2016, European heart journal.

[24]  Matthew S. Yong,et al.  Outcomes of Truncus Arteriosus Repair in Children: 35 Years of Experience From a Single Institution. , 2016, Seminars in thoracic and cardiovascular surgery.

[25]  I. V. Van Gelder,et al.  Sudden cardiac death in adult congenital heart disease: can the unpredictable be foreseen? , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[26]  O. Dekkers,et al.  Arrhythmogenic anatomical isthmuses identified by electroanatomical mapping are the substrate for ventricular tachycardia in repaired Tetralogy of Fallot , 2016, European heart journal.

[27]  L. Hudsmith,et al.  Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[28]  X. Jouven,et al.  Emergency Percutaneous Coronary Intervention in Post-Cardiac Arrest Patients Without ST-Segment Elevation Pattern: Insights From the PROCAT II Registry. , 2016, JACC. Cardiovascular interventions.

[29]  L. Eckardt,et al.  Long-time “real-life” performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillation , 2016, Journal of Interventional Cardiac Electrophysiology.

[30]  O. Tutarel,et al.  Cause of death in adults with congenital heart disease - An analysis of the German National Register for Congenital Heart Defects. , 2016, International journal of cardiology.

[31]  B. Mulder,et al.  Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis. , 2016, European heart journal.

[32]  M. Link,et al.  Clinical Presentation and Outcomes by Sex in Arrhythmogenic Right Ventricular Cardiomyopathy: Findings from the North American ARVC Registry , 2016, Journal of cardiovascular electrophysiology.

[33]  J. Siebermair,et al.  Early repolarization pattern is the strongest predictor of arrhythmia recurrence in patients with idiopathic ventricular fibrillation: results from a single centre long-term follow-up over 20 years. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[34]  C. Canniffe,et al.  Implantable cardioverter-defibrillators in a heart transplant population: A single-center experience. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[35]  P. Kudenchuk,et al.  Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Science Advisory From the American Heart Association , 2016, Circulation.

[36]  R. Furlan,et al.  Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope. , 2016, The Cochrane database of systematic reviews.

[37]  Raymond L Woosley,et al.  Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes. , 2016, Journal of the American College of Cardiology.

[38]  J. Cigarroa,et al.  Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2016, Circulation.

[39]  Hugh Calkins,et al.  2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2016, Circulation.

[40]  S. Priori,et al.  Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3 , 2016, Journal of the American College of Cardiology.

[41]  R. Hauer,et al.  Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2016, European heart journal.

[42]  A. Auricchio,et al.  True idiopathic ventricular fibrillation in out‐of‐hospital cardiac arrest survivors in the Swiss Canton Ticino: prevalence, clinical features, and long‐term follow‐up , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[43]  Andrea Mazzanti,et al.  2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.

[44]  Jagmeet P. Singh,et al.  2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing , 2016, Journal of arrhythmia.

[45]  Mark D. Huffman,et al.  Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association , 2016, Circulation.

[46]  H. Mallidi,et al.  Safety and Feasibility of Open Chest Epicardial Mapping and Ablation of Ventricular Tachycardia During the Period of Left Ventricular Assist Device Implantation , 2016, Journal of cardiovascular electrophysiology.

[47]  Amit R. Patel,et al.  Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction , 2016, Circulation. Cardiovascular imaging.

[48]  S. Brunak,et al.  Familial Atrial Septal Defect and Sudden Cardiac Death: Identification of a Novel NKX2‐5 Mutation and a Review of the Literature , 2015, Congenital heart disease.

[49]  G. Rada,et al.  Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death. , 2015, The Cochrane database of systematic reviews.

[50]  D. Lin,et al.  Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy , 2015, Circulation. Arrhythmia and electrophysiology.

[51]  J. Brugada,et al.  Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation , 2015, Circulation. Arrhythmia and electrophysiology.

[52]  S. Viskin,et al.  Management of Brugada Syndrome: Thirty-Three–Year Experience Using Electrophysiologically Guided Therapy With Class 1A Antiarrhythmic Drugs , 2015, Circulation. Arrhythmia and electrophysiology.

[53]  K. Cao,et al.  Catheter Ablation of Fascicular Ventricular Tachycardia , 2015, Circulation. Arrhythmia and electrophysiology.

[54]  C. Semsarian,et al.  Molecular autopsy in victims of inherited arrhythmias , 2015, Journal of arrhythmia.

[55]  P. Ellinor,et al.  Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis , 2016, Circulation.

[56]  Roger D. White,et al.  Part 7: Adult Advanced Cardiovascular Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. , 2015, Circulation.

[57]  C. Callaway,et al.  Cardiac Arrest in Pregnancy: A Scientific Statement From the American Heart Association , 2015, Circulation.

[58]  W. Shen,et al.  Advances in the pharmacologic treatment of ventricular arrhythmias , 2015, Expert opinion on pharmacotherapy.

[59]  E. Kaufman,et al.  Long‐QT Syndrome and Therapy for Attention Deficit/Hyperactivity Disorder , 2015, Journal of cardiovascular electrophysiology.

[60]  P. Brugada,et al.  Asymptomatic Brugada Syndrome: Clinical Characterization and Long-Term Prognosis , 2015, Circulation. Arrhythmia and electrophysiology.

[61]  S. Szymkiewicz,et al.  Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[62]  Sameer Parpia,et al.  The prevalence and significance of a short QT interval in 18 825 low-risk individuals including athletes , 2015, British Journal of Sports Medicine.

[63]  K. Dimopoulos,et al.  Survival Prospects and Circumstances of Death in Contemporary Adult Congenital Heart Disease Patients Under Follow-Up at a Large Tertiary Centre , 2015, Circulation.

[64]  Dhanunjaya R. Lakkireddy,et al.  Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study. , 2015, Heart rhythm.

[65]  A. Zwinderman,et al.  Secundum atrial septal defect is associated with reduced survival in adult men , 2015 .

[66]  M. Link,et al.  Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2015, Circulation.

[67]  P. Brugada,et al.  Prognostic Value of Programmed Electrical Stimulation in Brugada Syndrome: 20 Years Experience , 2015, Circulation. Arrhythmia and electrophysiology.

[68]  D. Delurgio,et al.  Outcome of Subcutaneous Implantable Cardioverter Defibrillator Implantation in Patients with End‐Stage Renal Disease on Dialysis , 2015, Journal of cardiovascular electrophysiology.

[69]  M. Link,et al.  Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy. , 2015, European heart journal.

[70]  R. Kobza,et al.  Utility of electrophysiological studies to predict arrhythmic events. , 2015, World journal of cardiology.

[71]  L. Cooper,et al.  Long-term risk of recurrence, morbidity and mortality in giant cell myocarditis. , 2015, The American journal of cardiology.

[72]  W. Stevenson,et al.  Role of Alternative Interventional Procedures When Endo- and Epicardial Catheter Ablation Attempts for Ventricular Arrhythmias Fail , 2015, Circulation. Arrhythmia and electrophysiology.

[73]  W. Stevenson,et al.  Surgical cryoablation for ventricular tachyarrhythmia arising from the left ventricular outflow tract region. , 2015, Heart rhythm.

[74]  Jeffrey M. Vinocur,et al.  Catecholaminergic Polymorphic Ventricular Tachycardia in Children: Analysis of Therapeutic Strategies and Outcomes From an International Multicenter Registry , 2015, Circulation. Arrhythmia and electrophysiology.

[75]  J. Lusson,et al.  A systematic variant screening in familial cases of congenital heart defects demonstrates the usefulness of molecular genetics in this field , 2015, European Journal of Human Genetics.

[76]  Pier D. Lambiase,et al.  Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry. , 2015, Journal of the American College of Cardiology.

[77]  Takumi Yamada,et al.  Radiofrequency Catheter Ablation of Idiopathic Ventricular Arrhythmias Originating From Intramural Foci in the Left Ventricular Outflow Tract: Efficacy of Sequential Versus Simultaneous Unipolar Catheter Ablation , 2015, Circulation. Arrhythmia and electrophysiology.

[78]  H. Calkins,et al.  Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2015, Heart rhythm.

[79]  J. Seidman,et al.  NKX2-5 Mutations in an Inbred Consanguineous Population: Genetic and Phenotypic Diversity , 2015, Scientific Reports.

[80]  San-Kuei Huang,et al.  Arrhythmic burdens in patients with tetralogy of Fallot: a national database study. , 2015, Heart rhythm.

[81]  J. Airaksinen,et al.  Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. , 2015, Circulation.

[82]  Hiroshi Ito,et al.  Outcomes in patients with high-degree atrioventricular block as the initial manifestation of cardiac sarcoidosis. , 2015, The American journal of cardiology.

[83]  Paul L. Hess,et al.  Catheter Ablation for Ventricular Tachycardia in Patients with an Implantable Cardioverter Defibrillator (CALYPSO) Pilot Trial , 2015, Journal of cardiovascular electrophysiology.

[84]  H. Schaff,et al.  Ventricular Arrhythmia Risk Stratification in Patients With Tetralogy of Fallot at the Time of Pulmonary Valve Replacement , 2015, Circulation. Arrhythmia and electrophysiology.

[85]  Yu-Feng Hu,et al.  Long-term outcome of multiform premature ventricular complexes in structurally normal heart. , 2015, International journal of cardiology.

[86]  V. Russo,et al.  ICD role in preventing sudden cardiac death in Emery-Dreifuss muscular dystrophy with preserved myocardial function: 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[87]  J. Kautzner,et al.  Role of electrophysiological studies in predicting risk of ventricular arrhythmia in early repolarization syndrome. , 2015, Journal of the American College of Cardiology.

[88]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[89]  Shawn D. Feinstein,et al.  Magnetic Resonance Imaging for Identifying Patients With Cardiac Sarcoidosis and Preserved or Mildly Reduced Left Ventricular Function at Risk of Ventricular Arrhythmias , 2014, Circulation. Arrhythmia and electrophysiology.

[90]  L. Morrison,et al.  Trends in Short- and Long-Term Survival Among Out-of-Hospital Cardiac Arrest Patients Alive at Hospital Arrival , 2014, Circulation.

[91]  W. Book,et al.  Lesion‐Specific Differences for Implantable Cardioverter Defibrillator Therapies in Adults with Congenital Heart Disease , 2014, Pacing and clinical electrophysiology : PACE.

[92]  G. Barón-Esquivias,et al.  Prognostic value of the electrocardiogram in patients with syncope: data from the group for syncope study in the emergency room (GESINUR). , 2014, Heart rhythm.

[93]  Donna K Arnett,et al.  AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and U.S. Department of Health and Human Services. , 2014, Journal of the American College of Cardiology.

[94]  T. Edvardsen,et al.  Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members , 2014, European journal of heart failure.

[95]  S. Kaufman,et al.  “It's Not Broke, So Let's Not Try to Fix It”: Why Patients Decline a Cardiovascular Implantable Electronic Device , 2014, Pacing and clinical electrophysiology : PACE.

[96]  John K. Triedman,et al.  PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: Executive Summary , 2014 .

[97]  P. Kirchhof,et al.  EHRA / HRS / APHRS expert consensus on ventricular arrhythmias , 2014 .

[98]  Jeffrey L. Anderson,et al.  The Evolution and Future of ACC/AHA Clinical Practice Guidelines: A 30-Year Journey A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[99]  A. Moss,et al.  Efficacy of different beta-blockers in the treatment of long QT syndrome. , 2014, Journal of the American College of Cardiology.

[100]  N. Buckley,et al.  Digoxin-specific antibody fragments in the treatment of digoxin toxicity , 2014, Clinical toxicology.

[101]  J. Kovach,et al.  Arrhythmias and sudden death among older children and young adults following tetralogy of Fallot repair in the current era: are previously reported risk factors still applicable? , 2014, Congenital heart disease.

[102]  Giuseppe Limongelli,et al.  A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). , 2014, European heart journal.

[103]  P. Brugada,et al.  Comparison of the patient-activated event recording system vs. traditional 24 h Holter electrocardiography in individuals with paroxysmal palpitations or dizziness. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[104]  M. Link,et al.  Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment. , 2014, Journal of the American College of Cardiology.

[105]  Amit R. Patel,et al.  HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. , 2014, Heart rhythm.

[106]  Diane Lacaille,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk , 2014 .

[107]  M. Link,et al.  B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias. , 2014, Heart rhythm.

[108]  M. Chung,et al.  HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. , 2014, Circulation.

[109]  Thoralf M Sundt,et al.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[110]  J. Healey,et al.  Procainamide infusion in the evaluation of unexplained cardiac arrest: from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER). , 2014, Heart rhythm.

[111]  E. Behr,et al.  The importance of specialist cardiac histopathological examination in the investigation of young sudden cardiac deaths. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[112]  B. Gersh,et al.  Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy. , 2014, Mayo Clinic proceedings.

[113]  A. Sato,et al.  Systematic Treatment Approach to Ventricular Tachycardia in Cardiac Sarcoidosis , 2014, Circulation. Arrhythmia and electrophysiology.

[114]  W. Kraus,et al.  Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure. , 2014, JACC. Heart failure.

[115]  C. Callaway,et al.  Time to administration of epinephrine and outcome after in-hospital cardiac arrest with non-shockable rhythms: retrospective analysis of large in-hospital data registry , 2014, BMJ : British Medical Journal.

[116]  B. Maron,et al.  Hypertrophic cardiomyopathy: one gene … but many phenotypes. , 2014, The American journal of cardiology.

[117]  M. Chung.  The role of the wearable cardioverter defibrillator in clinical practice. , 2014, Cardiology clinics.

[118]  S. Priori,et al.  Novel Insight Into the Natural History of Short QT Syndrome , 2014, Journal of the American College of Cardiology.

[119]  Johan Duflou,et al.  Exome analysis-based molecular autopsy in cases of sudden unexplained death in the young. , 2014, Heart rhythm.

[120]  Yingying Tang,et al.  Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths. , 2014, Forensic science international.

[121]  D. Stacey,et al.  Making Decisions About Implantable Cardioverter-Defibrillators from Implantation to End of Life: An Integrative Review of Patients’ Perspectives , 2014, The Patient - Patient-Centered Outcomes Research.

[122]  P. Lambiase,et al.  Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry , 2014, European heart journal.

[123]  K. Dimopoulos,et al.  Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality. , 2014, European heart journal.

[124]  A. Mahajan,et al.  Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. , 2014, Heart rhythm.

[125]  C. Kramer,et al.  Late Gadolinium Enhancement on Cardiac Magnetic Resonance Predicts Adverse Cardiovascular Outcomes in Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis , 2014, Circulation. Cardiovascular imaging.

[126]  V. Zipunnikov,et al.  Radiofrequency Ablation Versus Antiarrhythmic Medication for Treatment of Ventricular Premature Beats From the Right Ventricular Outflow Tract: Prospective Randomized Study , 2014, Circulation. Arrhythmia and electrophysiology.

[127]  A. Moss,et al.  Syncope in High-Risk Cardiomyopathy Patients With Implantable Defibrillators: Frequency, Risk Factors, Mechanisms, and Association With Mortality Results From the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT) Study , 2014, Circulation.

[128]  T. Dickfeld,et al.  Cardiac Sarcoidosis: Electrophysiological Outcomes on Long‐Term Follow‐Up and the Role of the Implantable Cardioverter‐Defibrillator , 2014, Journal of cardiovascular electrophysiology.

[129]  E. Cantero-Pérez,et al.  Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation. , 2013, Transplantation proceedings.

[130]  Young-Hoon Kim,et al.  Electrophysiological Characteristics Related to Outcome after Catheter Ablation of Idiopathic Ventricular Arrhythmia Originating from the Papillary Muscle in the Left Ventricle , 2013, Korean circulation journal.

[131]  Stefan L. Zimmerman,et al.  Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. , 2013, Journal of the American College of Cardiology.

[132]  P. Kudenchuk,et al.  Prophylactic lidocaine for post resuscitation care of patients with out-of-hospital ventricular fibrillation cardiac arrest. , 2013, Resuscitation.

[133]  J. Kalman,et al.  Familial cardiological and targeted genetic evaluation: low yield in sudden unexplained death and high yield in unexplained cardiac arrest syndromes. , 2013, Heart rhythm.

[134]  M. Olesen,et al.  High prevalence of genetic variants previously associated with Brugada syndrome in new exome data , 2013, Clinical genetics.

[135]  K. Gauvreau,et al.  Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort , 2013, Heart.

[136]  S. Kaptoge,et al.  Meta-analysis of ventricular premature complexes and their relation to cardiac mortality in general populations. , 2013, The American journal of cardiology.

[137]  S. Russell,et al.  Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. , 2013, Journal of the American College of Cardiology.

[138]  F. Anselme,et al.  Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders. , 2013, Heart rhythm.

[139]  E. Behr,et al.  Genetic testing for inherited cardiac disease , 2013, Nature Reviews Cardiology.

[140]  Wataru Shimizu,et al.  HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes , 2013 .

[141]  Katja Zeppenfeld,et al.  Contrast-Enhanced MRI–Derived Scar Patterns and Associated Ventricular Tachycardias in Nonischemic Cardiomyopathy: Implications for the Ablation Strategy , 2013, Circulation. Arrhythmia and electrophysiology.

[142]  A. Wilde,et al.  Mutation Location Effect on Severity of Phenotype During Exercise Testing in Type 1 Long‐QT Syndrome: Impact of Transmembrane and C‐Loop Location , 2013, Journal of cardiovascular electrophysiology.

[143]  M. O. Al Chekakie,et al.  Traditional heart failure medications and sudden cardiac death prevention: a review. , 2013, Journal of cardiovascular pharmacology and therapeutics.

[144]  Mark Kremers,et al.  Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator , 2013, Circulation.

[145]  M. Turakhia,et al.  Diagnostic utility of a novel leadless arrhythmia monitoring device. , 2013, The American journal of cardiology.

[146]  P. Kirchhof,et al.  Tachycardia detection performance of implantable loop recorders: results from a large 'real-life' patient cohort and patients with induced ventricular arrhythmias. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[147]  J. Roos‐Hesselink,et al.  The unnatural history of an atrial septal defect: Longitudinal 35 year follow up after surgical closure at young age , 2013, Heart.

[148]  R. Swor,et al.  Rapid epinephrine administration improves early outcomes in out-of-hospital cardiac arrest. , 2013, Resuscitation.

[149]  Y. Yokoyama,et al.  Prognosis and risk stratification of young adults with Brugada syndrome. , 2013, Journal of electrocardiology.

[150]  R. Hetzer,et al.  Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation , 2013, Heart.

[151]  H. Putter,et al.  Suitability for subcutaneous defibrillator implantation: results based on data from routine clinical practice , 2013, Heart.

[152]  J. Towbin,et al.  Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians. , 2013, Journal of the American College of Cardiology.

[153]  Perry M Elliott,et al.  A systematic review and meta-analysis of genotype–phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations , 2013, Heart.

[154]  C. Bhamidipati,et al.  Cryoablation during left ventricular assist device implantation reduces postoperative ventricular tachyarrhythmias. , 2013, The Journal of thoracic and cardiovascular surgery.

[155]  J. Atherton,et al.  Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy , 2013, Genetics in Medicine.

[156]  J. Chibnall,et al.  Patient perceptions, physician communication, and the implantable cardioverter-defibrillator. , 2013, JAMA internal medicine.

[157]  U. Kramer,et al.  CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. , 2013, JACC. Cardiovascular imaging.

[158]  Wataru Shimizu,et al.  Long-term follow-up of a pediatric cohort with short QT syndrome. , 2013, Journal of the American College of Cardiology.

[159]  Jagmeet P. Singh,et al.  Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[160]  L. Held,et al.  Usefulness of inducible ventricular tachycardia to predict long-term adverse outcomes in arrhythmogenic right ventricular cardiomyopathy. , 2013, The American journal of cardiology.

[161]  Deepak L. Bhatt,et al.  ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[162]  Tim Smith,et al.  The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis. , 2013, European heart journal.

[163]  K. Salmenkivi,et al.  Diagnosis, Treatment, and Outcome of Giant-Cell Myocarditis in the Era of Combined Immunosuppression , 2013, Circulation. Heart failure.

[164]  L. Køber,et al.  Penetrance of Hypertrophic Cardiomyopathy in Children and Adolescents: A 12-Year Follow-up Study of Clinical Screening and Predictive Genetic Testing , 2013, Circulation.

[165]  G. Trillò,et al.  Impact of emergency coronary angiography on in-hospital outcome of unconscious survivors after out-of-hospital cardiac arrest. , 2012, The American journal of cardiology.

[166]  S. Szymkiewicz,et al.  Wearable defibrillator use in heart failure (WIF): results of a prospective registry , 2012, BMC Cardiovascular Disorders.

[167]  R. Hauer,et al.  Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers. , 2015, European heart journal.

[168]  S. Russell,et al.  Risk Stratification in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy–Associated Desmosomal Mutation Carriers , 2012, Circulation. Arrhythmia and electrophysiology.

[169]  L. Jordaens,et al.  The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. , 2012, Journal of the American College of Cardiology.

[170]  W. Groh.  Arrhythmias in the muscular dystrophies. , 2012, Heart rhythm.

[171]  P. Schwartz,et al.  Spectrum and Prevalence of Mutations Involving Brs1-through Brs12-susceptibility Genes in a Cohort of Unrelated Patients Referred for Brugada Syndrome Genetic Testing Implications for Genetic Testing , 2022 .

[172]  M. Link,et al.  2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected]. , 2012, Circulation.

[173]  A. Peters,et al.  A meta-analysis of genome-wide association studies of the electrocardiographic early repolarization pattern. , 2012, Heart rhythm.

[174]  K. Mattocks,et al.  Patients’ Attitudes and Perceptions of Implantable Cardioverter‐Defibrillators: Potential Barriers to Appropriate Primary Prophylaxis , 2012, Pacing and clinical electrophysiology : PACE.

[175]  B. Sunsaneewitayakul,et al.  Endocardial Mapping and Catheter Ablation for Ventricular Fibrillation Prevention in Brugada Syndrome , 2012, Journal of cardiovascular electrophysiology.

[176]  Thomas C. Crawford,et al.  Implantable Cardioverter Defibrillator Therapy in Patients with Cardiac Sarcoidosis , 2012, Journal of cardiovascular electrophysiology.

[177]  J. Deharo,et al.  Electrical Storm in Short‐QT Syndrome Successfully Treated with Isoproterenol , 2012, Journal of cardiovascular electrophysiology.

[178]  M. Steinmetz,et al.  Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome , 2012, Clinical Research in Cardiology.

[179]  J. López-Sendón,et al.  Incidence and predictors of sudden cardiac arrest in adults with congenital heart defects repaired before adult life. , 2012, The American journal of cardiology.

[180]  F. Pluchinotta,et al.  Coronary Arteries in Childhood Heart Disease: Implications for Management of Young Adults. , 2012, Journal of clinical & experimental cardiology.

[181]  D. Tester,et al.  Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing. , 2012, Mayo Clinic proceedings.

[182]  E. Kaufman,et al.  Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome. , 2012, Heart rhythm.

[183]  S. Russell,et al.  Outcomes of Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2012, Circulation. Arrhythmia and electrophysiology.

[184]  A. Wilde,et al.  The phenomenon of "QT stunning": the abnormal QT prolongation provoked by standing persists even as the heart rate returns to normal in patients with long QT syndrome. , 2012, Heart rhythm.

[185]  K. Dimopoulos,et al.  Left Ventricular Longitudinal Function Predicts Life-Threatening Ventricular Arrhythmia and Death in Adults With Repaired Tetralogy of Fallot , 2012, Circulation.

[186]  C. Kramer,et al.  Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. , 2012, JACC. Cardiovascular imaging.

[187]  A. Hagihara,et al.  Prehospital epinephrine use and survival among patients with out-of-hospital cardiac arrest. , 2012, JAMA.

[188]  Jon Hainer,et al.  Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. , 2012, Journal of the American College of Cardiology.

[189]  M Juhani Junttila,et al.  Sudden Cardiac Death Caused by Coronary Heart Disease , 2012, Circulation.

[190]  J. Brugada,et al.  Combined Endocardial and Epicardial Catheter Ablation in Arrhythmogenic Right Ventricular Dysplasia Incorporating Scar Dechanneling Technique , 2012, Circulation. Arrhythmia and electrophysiology.

[191]  I. V. Van Gelder,et al.  Implantable Cardioverter Defibrillator Therapy in Adults With Congenital Heart Disease: Who Is at Risk of Shocks? , 2012, Circulation. Arrhythmia and electrophysiology.

[192]  G. Eide,et al.  Predictors of Heart-Focused Anxiety in Patients Undergoing Genetic Investigation and Counseling of Long QT Syndrome or Hypertrophic Cardiomyopathy: A One Year Follow-up , 2012, Journal of Genetic Counseling.

[193]  D. Grobbee,et al.  Circumstances of death in adult congenital heart disease. , 2012, International journal of cardiology.

[194]  V. Froelicher,et al.  Natural history of the electrocardiographic pattern of early repolarization in ambulatory patients. , 2011, The American journal of cardiology.

[195]  Changyu Shen,et al.  Pacemaker and Implantable Cardioverter‐Defibrillator Use in a US Myotonic Dystrophy Type 1 Population , 2011, Journal of cardiovascular electrophysiology.

[196]  John Spertus,et al.  AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. , 2011, Circulation.

[197]  L. Fauchier,et al.  The evolution of infrahissian conduction time in myotonic dystrophy patients: clinical implications , 2011, Heart.

[198]  D. Tester,et al.  Unexplained drownings and the cardiac channelopathies: a molecular autopsy series. , 2011, Mayo Clinic proceedings.

[199]  H. Huikuri,et al.  Causes of nonischemic sudden cardiac death in the current era. , 2011, Heart rhythm.

[200]  Michael J Ackerman,et al.  Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome. , 2011, Heart rhythm.

[201]  S. Russell,et al.  Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. , 2011, Journal of the American College of Cardiology.

[202]  J. Finn,et al.  Effect of adrenaline on survival in out-of-hospital cardiac arrest: A randomised double-blind placebo-controlled trial. , 2011, Resuscitation.

[203]  Andrea Mazzanti,et al.  Long-term follow-up of patients with short QT syndrome. , 2011, Journal of the American College of Cardiology.

[204]  M. Acker,et al.  Surgical Ablation of Refractory Ventricular Tachycardia in Patients With Nonischemic Cardiomyopathy , 2011, Circulation. Arrhythmia and electrophysiology.

[205]  Michael J Ackerman,et al.  HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[206]  A. Verma,et al.  Ablation of Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Arrhythmia-Free Survival After Endo-Epicardial Substrate Based Mapping and Ablation , 2011, Circulation. Arrhythmia and electrophysiology.

[207]  P. Lambiase,et al.  The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy , 2011, Heart.

[208]  L. Fauchier,et al.  Mortality in myotonic dystrophy patients in the area of prophylactic pacing devices. , 2011, International journal of cardiology.

[209]  P. Elliott,et al.  Familial Evaluation in Arrhythmogenic Right Ventricular Cardiomyopathy: Impact of Genetics and Revised Task Force Criteria , 2011, Circulation.

[210]  R. Hauer,et al.  Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. , 2011, Journal of the American College of Cardiology.

[211]  B. Yashiro,et al.  Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. , 2011, Journal of the American College of Cardiology.

[212]  H. Shimokawa,et al.  Clinical Characteristics and Long-Term Prognosis of Vasospastic Angina Patients Who Survived Out-of-Hospital Cardiac Arrest: Multicenter Registry Study of the Japanese Coronary Spasm Association , 2011, Circulation. Arrhythmia and electrophysiology.

[213]  N. Sitta,et al.  [Risk stratification in Brugada syndrome]. , 2011, Giornale italiano di cardiologia.

[214]  Wojciech Zareba,et al.  Risk Stratification for Arrhythmic Sudden Cardiac Death: Identifying the Roadblocks , 2011, Circulation.

[215]  A. Wilde,et al.  Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. , 2011, Journal of the American College of Cardiology.

[216]  C. Lory,et al.  Impact of routine percutaneous coronary intervention after out-of-hospital cardiac arrest due to ventricular fibrillation , 2011, Critical care.

[217]  P. Ho,et al.  Treatment and outcomes in patients with myocardial infarction treated with acute β-blocker therapy: results from the American College of Cardiology's NCDR(®). , 2011, American heart journal.

[218]  H. Calkins,et al.  Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease. , 2011, Heart rhythm.

[219]  Tachapong Ngarmukos,et al.  Prevention of Ventricular Fibrillation Episodes in Brugada Syndrome by Catheter Ablation Over the Anterior Right Ventricular Outflow Tract Epicardium , 2011, Circulation.

[220]  M. Friedrich,et al.  Impact of the revision of arrhythmogenic right ventricular cardiomyopathy/dysplasia task force criteria on its prevalence by CMR criteria. , 2011, JACC. Cardiovascular imaging.

[221]  M. Gollob,et al.  The short QT syndrome: proposed diagnostic criteria. , 2011, Journal of the American College of Cardiology.

[222]  Kevin L. Thomas,et al.  Systematic review of the incidence of sudden cardiac death in the United States. , 2011, Journal of the American College of Cardiology.

[223]  D. Bluemke,et al.  Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia. , 2011, Heart rhythm.

[224]  B. Caffo,et al.  Clinical Predictors of Conduction Disease Progression in Type I Myotonic Muscular Dystrophy , 2011, Pacing and clinical electrophysiology : PACE.

[225]  Michael J. Ackerman,et al.  Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. , 2011, Journal of the American College of Cardiology.

[226]  Changyu Shen,et al.  Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1. , 2010, American heart journal.

[227]  E. Kaufman,et al.  Trigger-specific risk factors and response to therapy in long QT syndrome type 2. , 2010, Heart rhythm.

[228]  Mark E. Anderson,et al.  Sudden Cardiac Death Prediction and Prevention: Report From a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop , 2010, Circulation.

[229]  J. Healey,et al.  Derivation and Validation of a Simple Exercise-Based Algorithm for Prediction of Genetic Testing in Relatives of LQTS Probands , 2011, Circulation.

[230]  B. Gersh,et al.  Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy. , 2010, The American journal of cardiology.

[231]  M. Shuster,et al.  Part 12: cardiac arrest in special situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. , 2010, Circulation.

[232]  B. Desjardins,et al.  Predictors of successful catheter ablation of ventricular arrhythmias arising from the papillary muscles. , 2010, Heart rhythm.

[233]  F. Gaita,et al.  Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach , 2010, European heart journal.

[234]  J. Hartikainen,et al.  Long-Term Recording of Cardiac Arrhythmias With an Implantable Cardiac Monitor in Patients With Reduced Ejection Fraction After Acute Myocardial Infarction: The Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) Study , 2010, Circulation.

[235]  M. Link,et al.  Prophylactic Implantable Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia and No Prior Ventricular Fibrillation or Sustained Ventricular Tachycardia , 2010, Circulation.

[236]  Joseph D. Kay,et al.  Arrhythmia Burden in Adults With Surgically Repaired Tetralogy of Fallot: A Multi-Institutional Study , 2010, Circulation.

[237]  I. Kowalik,et al.  Implantable Cardioverter‐Defibrillator in Patients With Hypertrophic Cardiomyopathy: Efficacy and Complications of the Therapy in Long‐Term Follow‐up , 2010, Journal of cardiovascular electrophysiology.

[238]  A. Moss,et al.  Beta‐Blocker Efficacy in High‐Risk Patients with the Congenital Long‐QT Syndrome Types 1 and 2: Implications for Patient Management , 2010, Journal of cardiovascular electrophysiology.

[239]  M. Chung,et al.  Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. , 2010, Journal of the American College of Cardiology.

[240]  A. Skanes,et al.  Utility of the recovery electrocardiogram after exercise: a novel indicator for the diagnosis and genotyping of long QT syndrome? , 2010, Heart rhythm.

[241]  P. Kudenchuk,et al.  Procainamide and survival in ventricular fibrillation out-of-hospital cardiac arrest. , 2010, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[242]  F. Morady,et al.  Ventricular arrhythmias originating from papillary muscles in the right ventricle. , 2010, Heart rhythm.

[243]  X. Jouven,et al.  Immediate Percutaneous Coronary Intervention Is Associated With Better Survival After Out-of-Hospital Cardiac Arrest: Insights From the PROCAT (Parisian Region Out of Hospital Cardiac Arrest) Registry , 2010, Circulation. Cardiovascular interventions.

[244]  A. Wilde,et al.  The Response of the QT Interval to the Brief Tachycardia Provoked by Standing: A Bedside Test for Diagnosing Long QT Syndrome , 2010 .

[245]  D. Grobbee,et al.  Mortality in adult congenital heart disease. , 2010, European heart journal.

[246]  Michael J Ackerman,et al.  Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations. , 2010, Journal of the American College of Cardiology.

[247]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, Circulation.

[248]  D. Atsma,et al.  The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening. , 2010, European heart journal.

[249]  M. Sheppard,et al.  Guidelines for autopsy investigation of sudden cardiac death , 2007, Virchows Archiv.

[250]  S. Szymkiewicz,et al.  Bridging a Temporary High Risk of Sudden Arrhythmic Death. Experience with the Wearable Cardioverter Defibrillator (WCD) , 2010, Pacing and clinical electrophysiology : PACE.

[251]  A. Moss,et al.  Risk of fatal arrhythmic events in long QT syndrome patients after syncope. , 2010, Journal of the American College of Cardiology.

[252]  Akshay S. Desai,et al.  Patient expectations from implantable defibrillators to prevent death in heart failure. , 2010, Journal of cardiac failure.

[253]  D. Pennell,et al.  Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance , 2010 .

[254]  Arthur L. Kellermann,et al.  Predictors of Survival From Out-of-Hospital Cardiac Arrest A Systematic Review and Meta-Analysis , 2013 .

[255]  G. Hindricks,et al.  Catheter Ablation of Recurrent Scar‐Related Ventricular Tachycardia Using Electroanatomical Mapping and Irrigated Ablation Technology: Results of the Prospective Multicenter Euro‐VT‐Study , 2010, Journal of cardiovascular electrophysiology.

[256]  A. Tajik,et al.  Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy , 2010, Circulation. Heart failure.

[257]  C. Terkelsen,et al.  Prevalence and significance of accelerated idioventricular rhythm in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. , 2009, The American journal of cardiology.

[258]  G. Kay,et al.  Electrocardiographic and Electrophysiological Characteristics in Idiopathic Ventricular Arrhythmias Originating From the Papillary Muscles in the Left Ventricle: Relevance for Catheter Ablation , 2009, Circulation. Arrhythmia and electrophysiology.

[259]  P. Roberts,et al.  Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta‐analysis , 2009, European journal of heart failure.

[260]  Louise Adamson,et al.  Does pulmonary valve replacement post repair of tetralogy of Fallot improve right ventricular function? , 2009, Interactive cardiovascular and thoracic surgery.

[261]  G. Breithardt,et al.  QT interval prolongation and risk for cardiac events in genotyped LQTS-index children , 2009, European Journal of Pediatrics.

[262]  G. Marcus,et al.  Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. , 2009, Journal of the American College of Cardiology.

[263]  F. Marchlinski,et al.  Epicardial Substrate and Outcome With Epicardial Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2009, Circulation.

[264]  P. Hauptman,et al.  Implantable defibrillators and cardiac resynchronization therapy in heart transplant recipients: results of a national survey. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[265]  W. Williams,et al.  Ventricular arrhythmias and sudden death in adults after a Mustard operation for transposition of the great arteries. , 2009, European heart journal.

[266]  G. Bonsel,et al.  Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: The patients' perspective , 2009, American journal of medical genetics. Part A.

[267]  H. Calkins,et al.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. , 2009, Heart rhythm.

[268]  H. Heidbuchel,et al.  Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[269]  M. Ackerman,et al.  Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery. , 2009, Heart rhythm.

[270]  A. Leenhardt,et al.  Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia , 2009, Circulation.

[271]  P. Armstrong,et al.  Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. , 2009, JAMA.

[272]  C. O'connor,et al.  Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials. , 2009, European heart journal.

[273]  C. Helmers,et al.  Cardiac dysrhythmias in patients with acute myocardial infarction. Relation to serum potassium level and prior diuretic therapy. , 2009, Acta medica Scandinavica.

[274]  J. Hulting.  In-hospital ventricular fibrillation and its relation to serum potassium. , 2009, Acta medica Scandinavica. Supplementum.

[275]  C. Autore,et al.  Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy , 2009, Circulation.

[276]  L. Mestroni,et al.  Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline. , 2009, Journal of cardiac failure.

[277]  H. Heidbuchel,et al.  Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. , 2009, Journal of the American College of Cardiology.

[278]  S. Hohnloser,et al.  The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. , 2009, Journal of the American College of Cardiology.

[279]  S. Priori,et al.  Yield of Genetic Screening in Inherited Cardiac Channelopathies: How to Prioritize Access to Genetic Testing , 2009, Circulation. Arrhythmia and electrophysiology.

[280]  S. Priori,et al.  High Efficacy of β-Blockers in Long-QT Syndrome Type 1: Contribution of Noncompliance and QT-Prolonging Drugs to the Occurrence of β-Blocker Treatment “Failures” , 2009, Circulation.

[281]  D. Grobbee,et al.  Long-term prognosis of congenital heart defects: a systematic review. , 2008, International journal of cardiology.

[282]  Warren M. Jackman,et al.  Irrigated Radiofrequency Catheter Ablation Guided by Electroanatomic Mapping for Recurrent Ventricular Tachycardia After Myocardial Infarction: The Multicenter Thermocool Ventricular Tachycardia Ablation Trial , 2008, Circulation.

[283]  S. Solomon,et al.  Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry). , 2008, The American journal of cardiology.

[284]  D. Mark,et al.  Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). , 2008, American heart journal.

[285]  Jeroen J. Bax,et al.  Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies. , 2008, JACC. Cardiovascular imaging.

[286]  S. Viskin,et al.  J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance. , 2008, Journal of the American College of Cardiology.

[287]  L. Tavazzi,et al.  Long-term outcome and risk stratification in dilated cardiolaminopathies. , 2008, Journal of the American College of Cardiology.

[288]  W. Manning,et al.  Response to Letter Regarding Article, “Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy” , 2009 .

[289]  L. Harris,et al.  Sudden Death and Defibrillators in Transposition of the Great Arteries With Intra-atrial Baffles: A Multicenter Study , 2008, Circulation. Arrhythmia and electrophysiology.

[290]  George A. Johnson,et al.  Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. , 2008, Journal of the American College of Cardiology.

[291]  G. Kay,et al.  Ventricular Tachycardia Originating From the Posterior Papillary Muscle in the Left Ventricle: A Distinct Clinical Syndrome , 2008, Circulation. Arrhythmia and electrophysiology.

[292]  L. Harris,et al.  Implantable Cardioverter-Defibrillators in Tetralogy of Fallot , 2008, Circulation.

[293]  Katja Zeppenfeld,et al.  Catheter Ablation of Ventricular Tachycardia After Repair of Congenital Heart Disease: Electroanatomic Identification of the Critical Right Ventricular Isthmus , 2007, Circulation.

[294]  R. Passman,et al.  Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. , 2007, Archives of Internal Medicine.

[295]  P. Tchou,et al.  Surgical Options for Refractory Ventricular Tachycardia , 2007, Journal of cardiac surgery.

[296]  A. Moss,et al.  Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. , 2007, Heart rhythm.

[297]  H. Sairanen,et al.  Causes of late deaths after pediatric cardiac surgery: a population-based study. , 2007, Journal of the American College of Cardiology.

[298]  Gerasimos S Filippatos,et al.  Drug-induced long QT syndrome. , 2007, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[299]  B. Vandermeer,et al.  Systematic Review: Implantable Cardioverter Defibrillators for Adults with Left Ventricular Systolic Dysfunction , 2007, Annals of Internal Medicine.

[300]  S. Russell,et al.  Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2007, Journal of the American College of Cardiology.

[301]  M. Link,et al.  Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. , 2007, JAMA.

[302]  B. Maron,et al.  Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy , 2007, Heart.

[303]  E. Kaufman,et al.  Long QT syndrome and pregnancy. , 2007, Journal of the American College of Cardiology.

[304]  Andrew J. Sauer,et al.  Long QT syndrome in adults. , 2007, Journal of the American College of Cardiology.

[305]  Pamela J Schreiner,et al.  Usefulness of ventricular premature complexes to predict coronary heart disease events and mortality (from the Atherosclerosis Risk In Communities cohort). , 2006, The American journal of cardiology.

[306]  L. Wilkins.  ACC/AHA/HRS 2006 Key Data Elements and Definitions for Electrophysiological Studies and Procedures , 2006 .

[307]  B. Maron,et al.  Determinants for clinical diagnosis of hypertrophic cardiomyopathy. , 2006, American Journal of Cardiology.

[308]  E P Walsh,et al.  Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair , 2006, Heart.

[309]  M. Schalij,et al.  Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: a multi-centre study. , 2006, European heart journal.

[310]  R. Lange,et al.  Presence of a Ventricular Septal Defect and the Mustard Operation Are Risk Factors for Late Mortality After the Atrial Switch Operation: Thirty Years of Follow-Up in 417 Patients at a Single Center , 2006, Circulation.

[311]  M. Borggrefe,et al.  Short QT syndrome: clinical findings and diagnostic-therapeutic implications. , 2006, European heart journal.

[312]  Michael J Ackerman,et al.  Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. , 2006, JAMA.

[313]  Dan M. Roden,et al.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines , 2006 .

[314]  P. Elliott,et al.  Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. , 2006, European heart journal.

[315]  L. Sharples,et al.  A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context. , 2006, Health technology assessment.

[316]  A. Tsiatis,et al.  Cost-Effectiveness of Defibrillator Therapy or Amiodarone in Chronic Stable Heart Failure: Results From the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) , 2006, Circulation.

[317]  R. Tawil,et al.  Facioscapulohumeral muscular dystrophy , 2006, Muscle & nerve.

[318]  Alvin I Mushlin,et al.  The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. , 2006, Journal of the American College of Cardiology.

[319]  A. Tajik,et al.  Use of echocardiography in patients with hypertrophic cardiomyopathy: clinical implications of massive hypertrophy. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[320]  J. A. Gomes,et al.  Risk Stratification of Individuals with the Brugada Electrocardiogram: A Meta‐Analysis , 2006, Journal of cardiovascular electrophysiology.

[321]  C. Snyder,et al.  Verapamil-sensitive ventricular tachycardia in an infant. , 2006, Congenital heart disease.

[322]  D. Tester,et al.  Effect of clinical phenotype on yield of long QT syndrome genetic testing. , 2006, Journal of the American College of Cardiology.

[323]  Y. Pinto,et al.  Primary prevention of sudden death in patients with lamin A/C gene mutations. , 2006, The New England journal of medicine.

[324]  E. Fain,et al.  Comparison of (cid:1) -Blockers, Amiodarone Plus (cid:1) -Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter Defibrillators The OPTIC Study: A Randomized Trial , 2005 .

[325]  S. Priori,et al.  Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. , 2005, JAMA.

[326]  J. Daubert,et al.  Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. , 2005, Journal of the American College of Cardiology.

[327]  J. Soar,et al.  European Resuscitation Council guidelines for resuscitation 2005. Section 4. Adult advanced life support. , 2005, Resuscitation.

[328]  S. Russell,et al.  Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. , 2005, Heart rhythm.

[329]  P. Engelfriet,et al.  The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. , 2005, European heart journal.

[330]  Douglas K Owens,et al.  Cost-effectiveness of implantable cardioverter-defibrillators. , 2005, The New England journal of medicine.

[331]  W. Shimizu,et al.  Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract. , 2005, Journal of the American College of Cardiology.

[332]  A. Moss,et al.  Cost‐Effectiveness of Implanted Defibrillators in Young People with Inherited Cardiac Arrhythmias , 2005, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[333]  A. Russo,et al.  Idiopathic fascicular left ventricular tachycardia: linear ablation lesion strategy for noninducible or nonsustained tachycardia. , 2005, Heart rhythm.

[334]  S. Viskin,et al.  The “Short‐Coupled” Variant of Right Ventricular Outflow Ventricular Tachycardia: A Not‐So‐Benign Form of Benign Ventricular Tachycardia? , 2005, Journal of cardiovascular electrophysiology.

[335]  D. Mehta,et al.  Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. , 2005, The American journal of cardiology.

[336]  S. Solomon,et al.  Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. , 2005, The New England journal of medicine.

[337]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[338]  G. Breithardt,et al.  Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up. , 2005, Heart rhythm.

[339]  J. Delaunay,et al.  Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculography. , 2005, In vivo.

[340]  R. Califf,et al.  Clinical and Economic Implications of the Multicenter Automatic Defibrillator Implantation Trial-II , 2005, Annals of Internal Medicine.

[341]  Yasuharu Matsumoto,et al.  Radiofrequency catheter ablation of premature ventricular complexes from right ventricular outflow tract improves left ventricular dilation and clinical status in patients without structural heart disease. , 2005, Journal of the American College of Cardiology.

[342]  B. Maron,et al.  Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations. , 2005, Journal of the American College of Cardiology.

[343]  I. Kakadiaris,et al.  Images in cardiovascular medicine. Detection of luminal-intimal border and coronary wall enhancement in intravascular ultrasound imaging after injection of microbubbles and simultaneous sonication with transthoracic echocardiography. , 2005, Circulation.

[344]  A. Nogami,et al.  Idiopathic ventricular arrhythmia arising from the mitral annulus: a distinct subgroup of idiopathic ventricular arrhythmias. , 2005, Journal of the American College of Cardiology.

[345]  Yves L Provost,et al.  Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. , 2005, The American journal of cardiology.

[346]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[347]  Akshay S. Desai,et al.  Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-analysis of Randomized Controlled Trials , 2004 .

[348]  Eric Fain,et al.  Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. , 2004, The New England journal of medicine.

[349]  S. Priori,et al.  CaV1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and Autism , 2004, Cell.

[350]  S. Priori,et al.  Association of Long QT Syndrome Loci and Cardiac Events Among Patients Treated With β-Blockers , 2004 .

[351]  L. Wilkins.  ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction , 2004 .

[352]  George A. Wells,et al.  Advanced Cardiac Life Support in Out-of-Hospital Cardiac Arrest , 2004 .

[353]  B. Hainque,et al.  Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome. , 2004, European heart journal.

[354]  J. Brugada,et al.  Radiofrequency Catheter Ablation for Arrhythmic Storm in Patients with An Implantable Cardioverter Defibrillator , 2004, Pacing and clinical electrophysiology : PACE.

[355]  D. Roden.  Drug-induced prolongation of the QT interval. , 2004, The New England journal of medicine.

[356]  N. Mok,et al.  Successful Use of Quinidine in Treatment of Electrical Storm in Brugada Syndrome , 2004, Pacing and clinical electrophysiology : PACE.

[357]  T. Suter,et al.  Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer. , 2004, Breast.

[358]  N. Freemantle,et al.  Clinical trials update and cumulative meta‐analyses from the American College of Cardiology: WATCH, SCD‐HeFT, DINAMIT, CASINO, INSPIRE, STRATUS‐US, RIO‐Lipids and cardiac resynchronisation therapy in heart failure , 2004, European journal of heart failure.

[359]  Hugh Calkins,et al.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.

[360]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[361]  W. Grimm,et al.  Arrhythmia Risk Stratification with Regard to Prophylactic Implantable Defibrillator Therapy in Patients with Dilated Cardiomyopathy , 2004, Herz.

[362]  E. Walsh,et al.  Value of Programmed Ventricular Stimulation After Tetralogy of Fallot Repair: A Multicenter Study , 2004, Circulation.

[363]  S. Priori,et al.  Left Cardiac Sympathetic Denervation in the Management of High-Risk Patients Affected by the Long-QT Syndrome , 2004, Circulation.

[364]  S. Viskin,et al.  Long-term prognosis of inducible ventricular flutter: not an innocent finding , 2004 .

[365]  E. Ferrari,et al.  [Cardiotoxicity associated with trastuzumab (herceptin). An undesired effect leads towards a model of cardiac insufficiency]. , 2004, Archives des maladies du coeur et des vaisseaux.

[366]  A. Capucci,et al.  ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe. , 2004, European heart journal.

[367]  W. Stevenson,et al.  Identification and Ablation of Three Types of Ventricular Tachycardia Involving the His‐Purkinje System in Patients with Heart Disease , 2004, Journal of cardiovascular electrophysiology.

[368]  D. Roden,et al.  Suppression of Bidirectional Ventricular Tachycardia and Unmasking of Prolonged QT interval with Verapamil in Andersen's Syndrome , 2004, Journal of cardiovascular electrophysiology.

[369]  M. Link,et al.  Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2003, Circulation.

[370]  J. Brugada,et al.  Determinants of Sudden Cardiac Death in Individuals With the Electrocardiographic Pattern of Brugada Syndrome and No Previous Cardiac Arrest , 2003, Circulation.

[371]  Karl Swedberg,et al.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.

[372]  V. Santinelli,et al.  A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome. , 2003, The New England journal of medicine.

[373]  Barry J Maron,et al.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, Journal of the American College of Cardiology.

[374]  D. Faxon,et al.  ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca , 2003, Journal of the American College of Cardiology.

[375]  P. Elliott,et al.  Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. , 2003, Journal of the American College of Cardiology.

[376]  C. Chi,et al.  Verapamil sensitive idiopathic ventricular tachycardia in an infant. , 2003, Japanese heart journal.

[377]  J. Sanderson,et al.  Ablation of Nonsustained or Hemodynamically Unstable Ventricular Arrhythmia Originating From the Right Ventricular Outflow Tract Guided by Noncontact Mapping , 2003, Pacing and clinical electrophysiology : PACE.

[378]  H. Heidbuchel,et al.  High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification. , 2003, European heart journal.

[379]  Heikki V Huikuri,et al.  Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. , 2003, Circulation.

[380]  M. Link,et al.  Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. , 2003, Circulation.

[381]  F. Morady,et al.  Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT. , 2003, Journal of the American College of Cardiology.

[382]  Carlo Napolitano,et al.  Risk stratification in the long-QT syndrome. , 2003, The New England journal of medicine.

[383]  Ian Wilcox,et al.  Obstructive sleep apnea and cardiovascular disease. , 2005, Chest.

[384]  D. Pennell,et al.  Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.

[385]  Douglas S Lee,et al.  Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. , 2003, Journal of the American College of Cardiology.

[386]  B. Pitt,et al.  Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .

[387]  A. Moss,et al.  Implantable Cardioverter Defibrillator in High‐Risk Long QT Syndrome Patients , 2003, Journal of cardiovascular electrophysiology.

[388]  T. Sacchi,et al.  Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations. , 2003, International journal of cardiology.

[389]  S. Viskin,et al.  Long QT syndrome caused by noncardiac drugs. , 2003, Progress in cardiovascular diseases.

[390]  P. Armstrong,et al.  Implantable Cardioverter Defibrillators in Primary and Secondary Prevention , 2003, Annals of Internal Medicine.

[391]  M. Lauer,et al.  Frequent ventricular ectopy after exercise as a predictor of death. , 2003, The New England journal of medicine.

[392]  M. Copass,et al.  Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000. , 2002, JAMA.

[393]  R. Krittayaphong,et al.  Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study. , 2002, American heart journal.

[394]  G. de Martino,et al.  MYOTONIC DYSTROPHY AND THE HEART , 2002, Heart.

[395]  M. Josephson,et al.  Relation of Ejection Fraction and Inducible Ventricular Tachycardia to Mode of Death in Patients With Coronary Artery Disease: An Analysis of Patients Enrolled in the Multicenter Unsustained Tachycardia Trial , 2002, Circulation.

[396]  R. Vonthein,et al.  Efficacy of Metoprolol and Sotalol in the Prevention of Recurrences of Sustained Ventricular Tachyarrhythmias in Patients with an Implantable Cardioverter Defibrillator , 2002, Pacing and clinical electrophysiology : PACE.

[397]  R. Kerber,et al.  ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). , 2002, Circulation.

[398]  Lance B Becker,et al.  Public use of automated external defibrillators. , 2002, The New England journal of medicine.

[399]  C. Haffajee,et al.  Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia. , 2002, The American journal of cardiology.

[400]  R. Kerber,et al.  ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). , 2002, Circulation.

[401]  E. Antman,et al.  ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). , 2002, Journal of the American College of Cardiology.

[402]  G. Sanders,et al.  Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator. , 2002, American heart journal.

[403]  M. Holzer,et al.  Survivors of ventricular tachyarrhythmias due to a transient or reversible disorder have a high recurrence rate of lethal cardiac events. , 2002, Resuscitation.

[404]  F. Cappuccio,et al.  Variant of SCN5A Sodium Channel Implicated in Risk of Cardiac Arrhythmia , 2002, Science.

[405]  M. Shoda,et al.  Mapping and Ablation of Idiopathic Ventricular Fibrillation , 2002, Circulation.

[406]  B. Maron,et al.  Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. , 2002, Journal of the American College of Cardiology.

[407]  W. Kamps,et al.  Cardiac status in bone tumor survivors up to nearly 19 years after treatment with doxorubicin: a longitudinal study. , 2002, Medical and pediatric oncology.

[408]  R. Califf,et al.  Sustained Ventricular Arrhythmias Among Patients With Acute Coronary Syndromes With No ST-Segment Elevation: Incidence, Predictors, and Outcomes , 2002, Circulation.

[409]  Carlo Napolitano,et al.  Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia , 2002, Circulation.

[410]  R. Swanton,et al.  Mortality from infective endocarditis: clinical predictors of outcome , 2002, Heart.

[411]  A. Tajik,et al.  Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective. , 2002, Journal of the American College of Cardiology.

[412]  R. Berger,et al.  B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure , 2002, Circulation.

[413]  Judy Powell,et al.  Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry. , 2002, American heart journal.

[414]  B. Strasberg,et al.  Usefulness of implantable cardioverter-defibrillators in refractory variant angina pectoris complicated by ventricular fibrillation in patients with angiographically normal coronary arteries. , 2002, The American journal of cardiology.

[415]  K. McDonald,et al.  Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries , 2002 .

[416]  G. Larsen,et al.  Cost-Effectiveness of the Implantable Cardioverter-Defibrillator Versus Antiarrhythmic Drugs in Survivors of Serious Ventricular Tachyarrhythmias: Results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Economic Analysis Substudy , 2002, Circulation.

[417]  P. C. Viswanathan,et al.  Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes , 2002, Circulation.

[418]  G. Corrado,et al.  Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. , 2002, The American journal of cardiology.

[419]  K. Kuck,et al.  Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy: The Cardiomyopathy Trial (CAT) , 2002, Circulation.

[420]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[421]  P. Dorian,et al.  Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. , 2002, The New England journal of medicine.

[422]  W. Aronow,et al.  Prevalence and association of ventricular tachycardia and complex ventricular arrhythmias with new coronary events in older men and women with and without cardiovascular disease. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.

[423]  M. Mckee,et al.  Is the link between alcohol and cardiovascular death among young Russian men attributable to misclassification of acute alcohol intoxication? Evidence from the city of Izhevsk , 2002, Journal of epidemiology and community health.

[424]  Michel Haïssaguerre,et al.  Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation , 2002, The Lancet.

[425]  S. Ernst,et al.  Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation. , 2002, Journal of the American College of Cardiology.

[426]  M. Isobe,et al.  National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee). , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[427]  C. Jagger,et al.  A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation , 2002, Emergency medicine journal : EMJ.

[428]  C. Piot,et al.  QRS and Cycle Length Alternans During Paroxysmal Supraventricular Tachycardia: What is the Mechanism? , 2002, Journal of cardiovascular electrophysiology.

[429]  R. Koster.  Automatic External Defibrillator: Key Link in the Chain of Survival , 2002, Journal of cardiovascular electrophysiology.

[430]  J J Bailey,et al.  Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. , 2001, Journal of the American College of Cardiology.

[431]  M. Brodsky,et al.  Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up. , 2001, Journal of the American College of Cardiology.

[432]  H. Huikuri,et al.  Sudden death due to cardiac arrhythmias. , 2001, The New England journal of medicine.

[433]  W. Shen,et al.  Role of Programmed Ventricular Stimulation and Implantable Cardioverter Defibrillators in Patients with Idiopathic Dilated Cardiomyopathy and Syncope , 2001, Pacing and clinical electrophysiology : PACE.

[434]  M. Isobe,et al.  Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. , 2001, The American journal of cardiology.

[435]  George A. Mensah,et al.  Sudden Cardiac Death in the United States, 1989 to 1998 , 2001, Circulation.

[436]  P. Khairy.  Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction. , 2001, Journal of the American College of Cardiology.

[437]  G. Laufer,et al.  Survival Benefit of the Implantable Cardioverter-Defibrillator in Patients on the Waiting List for Cardiac Transplantation , 2001, Circulation.

[438]  A. Wilde,et al.  Quinidine Induced Electrocardiographic Normalization in Two Patients with Brugada Syndrome , 2001, Pacing and clinical electrophysiology : PACE.

[439]  M. Domanski,et al.  Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study , 2001 .

[440]  X. Jouven,et al.  Circulating Nonesterified Fatty Acid Level as a Predictive Risk Factor for Sudden Death in the Population , 2001, Circulation.

[441]  U Ravens,et al.  Task Force on Sudden Cardiac Death of the European Society of Cardiology. , 2001, European heart journal.

[442]  J. Petrauskiene,et al.  Daily variations in deaths in Lithuania: the possible contribution of binge drinking. , 2001, International journal of epidemiology.

[443]  S. Priori,et al.  Clinical Implications for Affected Parents and Siblings of Probands With Long-QT Syndrome , 2001, Circulation.

[444]  E. Aliot,et al.  Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology. , 2001, European heart journal.

[445]  E. Negri,et al.  Incidence and short-term prognosis of late sustained ventricular tachycardia after myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-3) Data Base. , 2001, American heart journal.

[446]  G. Schmidt,et al.  Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers. , 2001, Journal of the American College of Cardiology.

[447]  H. Dargie,et al.  Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.

[448]  A. Iwasa,et al.  Effects of verapamil and lidocaine on two components of the re-entry circuit of verapamil-senstitive idiopathic left ventricular tachycardia. , 2001, Journal of the American College of Cardiology.

[449]  J. Daubert,et al.  Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. , 2001, The New England journal of medicine.

[450]  M Gent,et al.  Cost-Effectiveness of the Implantable Cardioverter-Defibrillator: Results From the Canadian Implantable Defibrillator Study (CIDS) , 2001, Circulation.

[451]  P. J. Wang,et al.  Improving survival from sudden cardiac arrest: the role of the automated external defibrillator. , 2001, JAMA.

[452]  R. Myerburg,et al.  Sudden Cardiac Death: Exploring the Limits of Our Knowledge , 2001, Journal of cardiovascular electrophysiology.

[453]  P. Elliott,et al.  Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy , 2001, The Lancet.

[454]  J. Brugada,et al.  Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome. , 2001, Journal of the American College of Cardiology.

[455]  F. Morady,et al.  Brugada Syndrome Mimicked by Tricyclic Antidepressant Overdose , 2001, Journal of cardiovascular electrophysiology.

[456]  W. Grimm,et al.  Reversal of Tachycardia Induced Cardiomyopathy Following Ablation of Repetitive Monomorphic Right Ventricular Outflow Tract Tachycardia , 2001, Pacing and clinical electrophysiology : PACE.

[457]  R. Pass,et al.  Torsade de pointes in a child with acute rheumatic fever. , 2001, The Journal of pediatrics.

[458]  A. Hallstrom,et al.  “Stable” Ventricular Tachycardia Is Not a Benign Rhythm: Insights From the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry , 2001, Circulation.

[459]  P. Elliott,et al.  Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.

[460]  S. Connolly,et al.  Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. , 2000, European heart journal.

[461]  A. Rassi,et al.  Chagas' Heart Disease , 2000, Clinical cardiology.

[462]  S. Siu,et al.  Mode of death in adults with congenital heart disease. , 2000, The American journal of cardiology.

[463]  B. Eymard,et al.  High Incidence of Sudden Death with Conduction System and Myocardial Disease Due to Lamins A and C Gene Mutation , 2000, Pacing and clinical electrophysiology : PACE.

[464]  D J Roe,et al.  Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. , 2000, The New England journal of medicine.

[465]  E. Wellnhofer,et al.  Novel mutation in the alpha-tropomyosin gene and transition from hypertrophic to hypocontractile dilated cardiomyopathy. , 2000, Circulation.

[466]  X. Jouven,et al.  Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations , 2000 .

[467]  Y. Iesaka,et al.  Demonstration of diastolic and presystolic Purkinje potentials as critical potentials in a macroreentry circuit of verapamil-sensitive idiopathic left ventricular tachycardia. , 2000, Journal of the American College of Cardiology.

[468]  K. Nademanee,et al.  Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy. , 2000, Circulation.

[469]  R. Cappato,et al.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). , 2000, Circulation.

[470]  I. Gessner,et al.  Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. , 2000, Journal of the American College of Cardiology.

[471]  K. Lee,et al.  Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. , 2000, The New England journal of medicine.

[472]  B. Maron,et al.  Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[473]  J. Steinberg,et al.  Does an open infarct-related artery after myocardial infarction improve electrical stability? , 2000, Progress in cardiovascular diseases.

[474]  C. Fuller.  Cost effectiveness analysis of screening of high school athletes for risk of sudden cardiac death. , 2000, Medicine and science in sports and exercise.

[475]  G. Fonarow,et al.  Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator. , 2000, The American journal of cardiology.

[476]  E. Picano,et al.  Dobutamine Stress Echocardiography , 2000, Drug safety.

[477]  M Gent,et al.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.

[478]  A. Kadish,et al.  Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation , 2000, Pacing and clinical electrophysiology : PACE.

[479]  S. Priori,et al.  Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. , 2000, Circulation.

[480]  M. Link,et al.  Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[481]  H. Watkins.  Sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[482]  M. Elizari,et al.  Morbidity and mortality following early administration of amiodarone in acute myocardial infarction , 2000 .

[483]  R. Krittayaphong,et al.  Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease. , 2000, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[484]  R. Sung,et al.  A LONGITUDINAL STUDY OF CARDIAC FUNCTION IN CHILDREN WITH CANCER OVER 40 MONTHS , 2000, Pediatric hematology and oncology.

[485]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[486]  S. Connolly,et al.  Meta-analysis of antiarrhythmic drug trials. , 1999, The American journal of cardiology.

[487]  P. Kowey,et al.  Intravenous antiarrhythmic therapy in the acute control of in-hospital destabilizing ventricular tachycardia and fibrillation. , 1999, The American journal of cardiology.

[488]  J. Merino,et al.  Arrhythmias Associated with Neuromuscular Disorders , 1999 .

[489]  T. Miyazaki,et al.  Repetitive Monomorphic Ventricular Tachycardia of Left Coronary Cusp Origin , 1999, Pacing and clinical electrophysiology : PACE.

[490]  S. Markowitz,et al.  Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era. , 1999, Journal of the American College of Cardiology.

[491]  W. A. Murray,et al.  Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. , 1999, The New England journal of medicine.

[492]  J. Manson,et al.  Moderate alcohol consumption and the risk of sudden cardiac death among US male physicians. , 1999, Circulation.

[493]  J. Triedman,et al.  Value of Programmed Ventricular Stimulation in Patients with Congenital Heart Disease , 1999, Journal of cardiovascular electrophysiology.

[494]  A. Camm,et al.  Examining the psychosocial impact of implantable cardioverter defibrillators: A literature review , 1999, Clinical cardiology.

[495]  H. Inoue,et al.  Circadian variation of idiopathic ventricular tachycardia originating from right ventricular outflow tract. , 1999, The American journal of cardiology.

[496]  S. Hohnloser,et al.  Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. , 1999, The New England journal of medicine.

[497]  F. Morady,et al.  Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. , 1999, Journal of the American College of Cardiology.

[498]  B. Maron,et al.  Hypertrophic Cardiomyopathy Prognostic Value of Systemic Blood Pressure Response During Exercise in a Community-Based Patient Population With Hypertrophic Cardiomyopathy , 2016 .

[499]  T. Paul,et al.  Idiopathic ventricular tachycardia in infancy and childhood: a multicenter study on clinical profile and outcome. Working Group on Dysrhythmias and Electrophysiology of the Association for European Pediatric Cardiology. , 1999, Journal of the American College of Cardiology.

[500]  A. Camm,et al.  Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators. , 1999, Circulation.

[501]  P. Elliott,et al.  Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. , 1999, Journal of the American College of Cardiology.

[502]  J. Cigarroa,et al.  Late revascularization reduces mortality in survivors of myocardial infarction. , 1999, Cardiology in review.

[503]  P Ducimetière,et al.  Predicting sudden death in the population: the Paris Prospective Study I. , 1999, Circulation.

[504]  J. Farré,et al.  Amiodarone and "primary" prevention of sudden death: critical review of a decade of clinical trials. , 1999, The American journal of cardiology.

[505]  C. Kawai,et al.  From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. , 1999, Circulation.

[506]  R. Sciacca,et al.  New-onset sustained ventricular tachycardia after cardiac surgery. , 1999, Circulation.

[507]  R Yee,et al.  Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators. , 1999, Circulation.

[508]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[509]  David A. Leon,et al.  Alcohol and cardiovascular mortality in Moscow; new evidence of a causal association. , 1998, Journal of epidemiology and community health.

[510]  P. Carli,et al.  A Comparison of Repeated High Doses and Repeated Standard Doses of Epinephrine for Cardiac Arrest Outside the Hospital , 1998 .

[511]  J J Heger,et al.  Sudden cardiac death. , 1998, Circulation.

[512]  T. Imaizumi,et al.  Predictors of sudden cardiac death in hypertrophic cardiomyopathy. , 1998, The American journal of cardiology.

[513]  M. Reiter,et al.  Importance of beta blockade in the therapy of serious ventricular arrhythmias. , 1998, The American journal of cardiology.

[514]  M. Silka,et al.  A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. , 1998, Journal of the American College of Cardiology.

[515]  A I Mushlin,et al.  The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. , 1998, Circulation.

[516]  R. Woosley,et al.  Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence. , 1998, Journal of women's health.

[517]  A. Gotto,et al.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.

[518]  A. Castellanos,et al.  Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. , 1998, Circulation.

[519]  J. Thomas,et al.  Prognostic significance of exercise-induced left bundle-branch block. , 1998, JAMA.

[520]  Huabin Sun,et al.  The Value of Electrophysiology Study and Prophylactic Implantation of Cardioverter Defibrillator in Patients with Hypertrophic Cardiomyopathy , 1998, Pacing and clinical electrophysiology : PACE.

[521]  I. B. Kristensen,et al.  Arrhythmogenic right ventricular dysplasia as a cause of sudden death. , 1997, The American journal of forensic medicine and pathology.

[522]  P. Kokkinos,et al.  Value of the electrocardiogram in determining cardiac events and mortality in myotonic dystrophy. , 1997, The American journal of cardiology.

[523]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[524]  Bigger Jt,et al.  Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery , 1997 .

[525]  A. Castellanos,et al.  Clinical trials of implantable defibrillators. , 1997, The New England journal of medicine.

[526]  M. Davies,et al.  Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. , 1997, Journal of the American College of Cardiology.

[527]  M. Janse,et al.  Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials , 1997, The Lancet.

[528]  H. Wellens,et al.  Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival. , 1997, Journal of the American College of Cardiology.

[529]  E. Braunwald.  Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.

[530]  W. Mckenna,et al.  Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. , 1997, Circulation.

[531]  R. Califf,et al.  Randomised trial of magnesium in in-hospital cardiac arrest , 1997, The Lancet.

[532]  Geoffrey I. Webb,et al.  Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot. , 1997, Journal of the American College of Cardiology.

[533]  M. Jonas,et al.  Is immunosuppressive treatment an option for myocarditis? , 1997, Israel journal of medical sciences.

[534]  D. Roden,et al.  Normalization of acquired QT prolongation in humans by intravenous potassium. , 1997, Circulation.

[535]  G. Whipple,et al.  Prospective screening of 5,615 high school athletes for risk of sudden cardiac death. , 1997, Medicine and science in sports and exercise.

[536]  S. Markowitz,et al.  Adenosine-sensitive ventricular tachycardia: right ventricular abnormalities delineated by magnetic resonance imaging. , 1997, Circulation.

[537]  P. Brugada,et al.  Experience with implantable cardioverter defibrillator therapy in elderly patients. , 1997, European heart journal.

[538]  G. Berry,et al.  Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. , 1997, The New England journal of medicine.

[539]  J. Dhainaut,et al.  Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. , 1997, The New England journal of medicine.

[540]  L. Politano,et al.  Autonomic nervous system imbalance and left ventricular systolic dysfunction as potential candidates for arrhythmogenesis in Becker muscular dystrophy. , 1997, International journal of cardiology.

[541]  A. Coats,et al.  Variation in mode of sudden cardiac death in patients with dilated cardiomyopathy. , 1997, European heart journal.

[542]  L. Kunkel,et al.  Dystrophies and heart disease. , 1997, Current opinion in cardiology.

[543]  Y. Tai,et al.  Long‐term low‐dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: Efficacy and safety , 1997, Clinical cardiology.

[544]  K. Neumärker.  Mortality and sudden death in anorexia nervosa. , 1997, The International journal of eating disorders.

[545]  S. Connolly,et al.  Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT , 1997, The Lancet.

[546]  V. Preedy,et al.  Effects of alcohol on the heart , 1997, Current opinion in critical care.

[547]  P. Dorian,et al.  An overview of the management of electrical storm. , 1997, The Canadian journal of cardiology.

[548]  C. Caspersen,et al.  Risk Factors for Sudden Coronary Death in the United States , 1997, Epidemiology.

[549]  M. Biehl,et al.  Efficacy of the implantable cardioverter-defibrillator in the elderly. , 1997, Journal of the American College of Cardiology.

[550]  Paul J. Wang,et al.  Arrhythmogenic Right Ventricular Dysplasia: Clinical Results with Implantable Cardioverter Defibrillators , 1997, Journal of Interventional Cardiac Electrophysiology.

[551]  K. Jamrozik,et al.  Risk factors for sudden unexpected cardiac death in Tasmanian men. , 1997, Australian and New Zealand journal of medicine.

[552]  Á. S. Liprandi,et al.  Implantable Cardioverter Defibrillators in Patients with Chagas' Disease: Are They Different from Patients with Coronary Disease? , 1997, Pacing and clinical electrophysiology : PACE.

[553]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[554]  I. V. Van Gelder,et al.  Sudden Cardiac Death in Adult Congenital Heart Disease , 1996, Circulation.

[555]  F. Bu'Lock,et al.  Early identification of anthracycline cardiomyopathy: possibilities and implications. , 1996, Archives of disease in childhood.

[556]  Bertram Pitt,et al.  Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction , 1996, The Lancet.

[557]  R. Mulleneers,et al.  Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. , 1996, The American journal of cardiology.

[558]  J. Muñoz,et al.  Ventricular tachycardia in Duchenne's muscular dystrophy. , 1996, International journal of cardiology.

[559]  M. Zack,et al.  Comparison of sudden and nonsudden coronary deaths in the United States. , 1996, Circulation.

[560]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[561]  F. Marchlinski,et al.  Idiopathic right ventricular outflow tract tachycardia: narrowing the anatomic location for successful ablation. , 1996, American heart journal.

[562]  P. Gillette,et al.  Radiofrequency catheter ablation of right ventricular outflow tachycardia in children and adolescents. , 1996, Journal of the American College of Cardiology.

[563]  B. Suys,et al.  Dobutamine Stress Echocardiography in the Evaluation of Late Anthracycline Cardiotoxicity in Childhood Cancer Survivors , 1996, Pediatric Research.

[564]  J. Noonan,et al.  Late Echocardiographic Findings Following Childhood Chemotherapy with Normal Serial Cardiac Monitoring , 1996, Journal of pediatric hematology/oncology.

[565]  P. Tchou,et al.  Long‐Term Clinical Outcome of Right Bundle Branch Radiofrequency Catheter Ablation for Treatment of Bundle Branch Reentrant Ventricular Tachycardia , 1995, Pacing and clinical electrophysiology : PACE.

[566]  B. Maron,et al.  Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. , 1995, Journal of the American College of Cardiology.

[567]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[568]  S. Mittal.  Sudden cardiac death in hypertrophic cardiomyopathy: risk evaluation. , 1995, International journal of cardiology.

[569]  Chang Mau-Song,et al.  Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia , 1995 .

[570]  J. Etherington,et al.  Atrio-Ventricular Dissociation in Meningococcal Meningitis , 1995, Journal of the Royal Army Medical Corps.

[571]  W. Williams,et al.  Hypertrophic cardiomyopathy. Clinical spectrum and treatment. , 1995, Circulation.

[572]  D. Battleman,et al.  Mechanism of repetitive monomorphic ventricular tachycardia. , 1995, Circulation.

[573]  M. Scheinman.  NASPE Survey on Catheter Ablation , 1995, Pacing and clinical electrophysiology : PACE.

[574]  P C Deedwania,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.

[575]  E J Orav,et al.  Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. , 1995, The New England journal of medicine.

[576]  P. Steinherz,et al.  Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients. , 1995, Medical and pediatric oncology.

[577]  W. Aronow.  Treatment of Ventricular Arrhythmias in Older Adults , 1995, Journal of the American Geriatrics Society.

[578]  Nagi Ks,et al.  Lyme carditis: indications for cardiac pacing. , 1995, The Canadian journal of cardiology.

[579]  P. Macfarlane,et al.  Risk factors for sudden cardiac death in middle-aged British men. , 1995, Circulation.

[580]  A. Marian,et al.  Sudden cardiac death in hypertrophic cardiomyopathy , 1995 .

[581]  P. Coumel,et al.  Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. , 1995, Circulation.

[582]  A. Taylor,et al.  Evaluation of intravenous lidocaine for the termination of sustained monomorphic ventricular tachycardia in patients with coronary artery disease with or without healed myocardial infarction. , 1994, The American journal of cardiology.

[583]  V. Fuster,et al.  Idiopathic dilated cardiomyopathy. , 1994, The New England journal of medicine.

[584]  P. Spirito,et al.  Natural history of hypertrophic cardiomyopathy. , 1994, British heart journal.

[585]  G. Sinagra,et al.  Changing mortality in dilated cardiomyopathy , 1994 .

[586]  M. Burch,et al.  Hypertrophic cardiomyopathy. , 1994, Archives of disease in childhood.

[587]  R. Fluck,et al.  ACE inhibitors in non-diabetic renal disease. , 1994, British heart journal.

[588]  H. Doval,et al.  Randomised trial of low-dose amiodarone in severe congestive heart failure , 1994, The Lancet.

[589]  J. Uther,et al.  Double-blind trial of lignocaine versus sotalol for acute termination of spontaneous sustained ventricular tachycardia , 1994, The Lancet.

[590]  S. Winters,et al.  Current perspectives on sudden cardiac death in hypertrophic cardiomyopathy. , 1994, Progress in cardiovascular diseases.

[591]  L. Epstein,et al.  Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin. , 1994, Journal of the American College of Cardiology.

[592]  J. Ruskin,et al.  Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease. , 1994, Circulation.

[593]  E. Berbari,et al.  Late Potentials Are Unaffected by Radiofrequency Catheter Ablation in Patients with Ventricular Tachycardia , 1994, Pacing and clinical electrophysiology : PACE.

[594]  R. Myerburg,et al.  Sudden Cardiac Death: Epidemiology, Transient Risk, and Intervention Assessment , 1993, Annals of Internal Medicine.

[595]  Ralph Lazzara,et al.  Radiofrequency Catheter Ablation of Idiopathic Left Ventricular Tachycardia Guided by a Purkinje Potential , 1993, Circulation.

[596]  A. J. Dunning,et al.  Localization of the Site of Origin of Postinfarction Ventricular Tachycardia by Endocardial Pace Mapping Body Surface Mapping Compared With the 12‐Lead Electrocardiogram , 1993, Circulation.

[597]  A. Camm,et al.  Verapamil for the suppression of idiopathic ventricular tachycardia of left bundle branch block-like morphology. , 1993, American heart journal.

[598]  C. Furberg,et al.  Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. , 1993, JAMA.

[599]  Philip Sager,et al.  Identification of Reentry Circuit Sites During Catheter Mapping and Radiofrequency Ablation of Ventricular Tachycardia Late After Myocardial Infarction , 1993, Circulation.

[600]  A. Kadish,et al.  Effect of pregnancy on paroxysmal supraventricular tachycardia. , 1993, The American journal of cardiology.

[601]  A. Murray,et al.  Plasma potassium, serum magnesium and ventricular fibrillation: a prospective study. , 1993, The Quarterly journal of medicine.

[602]  J. Hoffman,et al.  Effect of hypertonic sodium bicarbonate in the treatment of moderate-to-severe cyclic antidepressant overdose. , 1993, The American journal of emergency medicine.

[603]  S. Deshpande,et al.  Bundle Branch Reentrant Ventricular Tachycardia: , 1993, Journal of cardiovascular electrophysiology.

[604]  M. Samuels.  Neurally induced cardiac damage. Definition of the problem. , 1993, Neurologic clinics.

[605]  H Calkins,et al.  Relation between efficacy of radiofrequency catheter ablation and site of origin of idiopathic ventricular tachycardia. , 1993, The American journal of cardiology.

[606]  M. Silka,et al.  Sudden Cardiac Death and the Use ofImplantable Cardioverter‐Defibrillators in Pediatric Patients , 1993, Circulation.

[607]  J. Langberg,et al.  Radiofrequency Catheter Ablation of Ventricular Tachycardia in Patients With Coronary Artery Disease , 1993, Circulation.

[608]  E. Prystowsky,et al.  Radiofrequency Catheter Ablation of Idiopathic Recurrent Ventricular Tachycardia with Right Bundle Branch Block, Left Axis Morphology , 1993, Pacing and clinical electrophysiology : PACE.

[609]  B. Lerman.  Response of Nonreentrant Catecholamine‐ Mediated Ventricular Tachycardia to Endogenous Adenosine and Acetycholine Evidence for Myocardial Receptor‐Mediated Effects , 1993, Circulation.

[610]  Norbertus C. Robben,et al.  The syndrome of 5‐fluorouracil cardiotoxicity. An elusive cardiopathy , 1993, Cancer.

[611]  D. Wilber,et al.  Adenosine‐Sensitive Ventricular Tachycardia Clinical Characteristics and Response to Catheter Ablation , 1993, Circulation.

[612]  C. Barton,et al.  A randomized clinical trial of high-dose epinephrine and norepinephrine vs standard-dose epinephrine in prehospital cardiac arrest. , 1992, JAMA.

[613]  J. Brugada,et al.  Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. , 1992, Journal of the American College of Cardiology.

[614]  A. Camm,et al.  Comparison of Verapamil and Diltiazem in the Suppression of Idiopathic Ventricular Tachycardia , 1992, Pacing and clinical electrophysiology : PACE.

[615]  A. G. Shaper,et al.  Alcohol and sudden cardiac death , 1992, British heart journal.

[616]  D. Wilber,et al.  Sudden death in idiopathic dilated cardiomyopathy. , 1992, American heart journal.

[617]  E. Antman,et al.  Declining Incidence of Ventricular Fibrillation in Myocardial Infarction: Implications for the Prophylactic Use of Lidocaine , 1992, Circulation.

[618]  B. Gersh,et al.  The Clinical Course of Idiopathic Dilated Cardiomyopathy , 1992, Annals of Internal Medicine.

[619]  W. Mckenna,et al.  The management of hypertrophic cardiomyopathy. , 1997, The New England journal of medicine.

[620]  W. Weaver,et al.  Influence of coronary bypass surgery on subsequent outcome of patients resuscitated from out of hospital cardiac arrest. , 1992, Journal of the American College of Cardiology.

[621]  Hue-Teh Shih,et al.  Radiofrequency Catheter Ablation of Ventricular Tachycardia in Patients Without Structural Heart Disease , 1992, Circulation.

[622]  M. Brodsky,et al.  New-onset ventricular tachycardia during pregnancy. , 1992, American heart journal.

[623]  S. Rahimtoola,et al.  WPW syndrome during pregnancy: increased incidence of supraventricular arrhythmias. , 1992, American heart journal.

[624]  P. Schwartz,et al.  Prevention of Sudden Cardiac Death After a First Myocardial Infarction by Pharmacologic or Surgical Antiadrenergic Interventions , 1992 .

[625]  L. Sjöström.  Mortality of severely obese subjects. , 1992, The American journal of clinical nutrition.

[626]  R. Berg,et al.  Dobutamine stress echocardiography: a sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer. , 1992, Journal of the American College of Cardiology.

[627]  J. Langberg,et al.  Radiofrequency catheter ablation for treatment of bundle branch reentrant ventricular tachycardia: results and long-term follow-up. , 1991, Journal of the American College of Cardiology.

[628]  J. Goin,et al.  Quinidine‐Related Mortality in the Short‐to‐Medium‐Term Treatment of Ventricular Arrhythmias: A Meta‐Analysis , 1991, Circulation.

[629]  Lippincott Williams Wilkins,et al.  The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. , 1991, Circulation.

[630]  J. Brugada,et al.  Clinical and electrophysiologic characteristics of exercise-related idiopathic ventricular tachycardia. , 1991, The American journal of cardiology.

[631]  A. Moss,et al.  The Long QT Syndrome: Prospective Longitudinal Study of 328 Families , 1991, Circulation.

[632]  J. Bourke,et al.  Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: results, optimal stimulation protocol and cost-effective screening. , 1991, Journal of the American College of Cardiology.

[633]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[634]  P. Gillette,et al.  Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. , 1991, Journal of the American College of Cardiology.

[635]  J. Ornato,et al.  Improving survival from sudden cardiac arrest: the "chain of survival" concept. A statement for health professionals from the Advanced Cardiac Life Support Subcommittee and the Emergency Cardiac Care Committee, American Heart Association. , 1991, Circulation.

[636]  H L Greene,et al.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.

[637]  Richard P. Lewis,et al.  ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Clinical Application of Echocard , 1990, Circulation.

[638]  H Calkins,et al.  Long-term results of catheter ablation of idiopathic right ventricular tachycardia. , 1990, Circulation.

[639]  U. Goldbourt,et al.  Prognosis of acute myocardial infarction complicated by primary ventricular fibrillation. Principal Investigators of the SPRINT Study. , 1990, The American journal of cardiology.

[640]  J. Schläpfer,et al.  Ten‐Years Follow‐Up of 20 Patients with Idiopathic Ventricular Tachycardia , 1990, Pacing and clinical electrophysiology : PACE.

[641]  J. Jais,et al.  Factors predicting mortality in idiopathic dilated cardiomyopathy. , 1990, European heart journal.

[642]  G. Divine,et al.  Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope. , 1990, The American journal of cardiology.

[643]  E. Antman,et al.  Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study. , 1990, Circulation.

[644]  M. Frenneaux,et al.  Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. , 1990, Journal of the American College of Cardiology.

[645]  G. Klein,et al.  Hemodynamic effects of intravenous procainamide during ventricular tachycardia. , 1990, American heart journal.

[646]  B. Craig,et al.  Ventricular Tachycardia Associated with Coxsackie B4 Virus Infection , 1990, Acta paediatrica Scandinavica.

[647]  B. Wilske,et al.  Persistent atrioventricular block in Lyme borreliosis , 1990, Klinische Wochenschrift.

[648]  P. Podrid.  Potassium and ventricular arrhythmias. , 1990, The American journal of cardiology.

[649]  A. Garson,et al.  Ventricular arrhythmias in postoperative tetralogy of Fallot. , 1990, The American journal of cardiology.

[650]  W. Stevenson,et al.  Facioscapulohumeral muscular dystrophy: evidence for selective, genetic electrophysiologic cardiac involvement. , 1990, Journal of the American College of Cardiology.

[651]  R. Gillum,et al.  Geographic variation in sudden coronary death. , 1990, American heart journal.

[652]  J. Ruskin,et al.  Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival. , 1990, Journal of the American College of Cardiology.

[653]  H. Huikuri,et al.  Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol. , 1989, Circulation.

[654]  W. Stevenson,et al.  Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. , 1989, Circulation.

[655]  D. Roden,et al.  Acute electrophysiologic effects of sodium administration in dogs treated with O-desmethyl encainide. , 1989, Circulation.

[656]  L. Edvinsson,et al.  Magnesium deficiency in coronary artery disease and cardiac arrhythmias , 1989, Journal of internal medicine.

[657]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[658]  A. Proclemer,et al.  Right Ventricular Tachycardia with Left Bundle Branch Block and Inferior Axis Morphology: Clinical and Arrhythmological Characteristics in 15 Patients , 1989, Pacing and clinical electrophysiology : PACE.

[659]  A. Maggioni,et al.  One-year prognosis of primary ventricular fibrillation complicating acute myocardial infarction. The GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto miocardico) investigators. , 1989, The American journal of cardiology.

[660]  D. Echt,et al.  Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation. , 1989, Circulation.

[661]  P. Brugada,et al.  Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart disease. , 1989, Circulation.

[662]  J. Hollifield.  Thiazide treatment of systemic hypertension: effects on serum magnesium and ventricular ectopic activity. , 1989, The American journal of cardiology.

[663]  W. Mckenna,et al.  Echocardiographic and histologic evaluation of the right ventricle in ventricular tachycardias of left bundle branch block morphology without overt cardiac abnormality. , 1989, The American journal of cardiology.

[664]  R. Gillum,et al.  Sudden coronary death in the United States: 1980-1985. , 1989, Circulation.

[665]  C. Schuger,et al.  Wide QRS tachycardia in the conscious adult. Ventricular tachycardia is the most frequent cause. , 1989, JAMA.

[666]  W. Kapoor,et al.  Long-term prognosis of patients undergoing electrophysiologic studies for syncope of unknown origin. , 1988, The American journal of cardiology.

[667]  R. Collins,et al.  Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. , 1988, JAMA.

[668]  P. Tchou,et al.  Transcatheter electrical ablation of right bundle branch. A method of treating macroreentrant ventricular tachycardia attributed to bundle branch reentry. , 1988, Circulation.

[669]  E. Drenick,et al.  Sudden cardiac arrest in morbidly obese surgical patients unexplained after autopsy. , 1988, American journal of surgery.

[670]  J. Mason,et al.  Prognostic significance of arrhythmia inducibility or noninducibility at initial electrophysiologic study in survivors of cardiac arrest. , 1988, The American journal of cardiology.

[671]  K. Kuck,et al.  Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope. , 1988, European heart journal.

[672]  A. Keren,et al.  Treatment of torsade de pointes with magnesium sulfate. , 1988, Circulation.

[673]  J. Ruskin,et al.  Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. , 1988, The New England journal of medicine.

[674]  P. J. Phillip,et al.  Recurrent seizures and syncope, ventricular arrhythmias with reversible prolonged Q-Tc interval in typhoid myocarditis. , 1987, Journal of the Indian Medical Association.

[675]  B. Deal,et al.  Electrophysiologic drug testing in symptomatic ventricular arrhythmias after repair of tetralogy of Fallot. , 1987, The American journal of cardiology.

[676]  P. Mcnair,et al.  Magnesium infusion reduces the incidence of arrhythmias in acute myocardial infarction. A double‐blind placebo‐controlled study , 1987, Clinical cardiology.

[677]  J. Kupersmith,et al.  Myotonic dystrophy: ambulatory electrocardiogram, electrophysiologic study, and echocardiographic evaluation. , 1987, American heart journal.

[678]  H. Lardoux,et al.  Efficacité de fortes doses de lactate molaire par voie veineuse lors des intoxications au flécaïnide. , 1987 .

[679]  M. Josephson,et al.  Hazards of intravenous verapamil for sustained ventricular tachycardia. , 1987, The American journal of cardiology.

[680]  A. S. Abraham,et al.  Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction. , 1987, Archives of internal medicine.

[681]  H. Zwerling.  Does exogenous magnesium suppress myocardial irritability and tachyarrhythmias in the nondigitalized patient? , 1987, American heart journal.

[682]  R. Bonow,et al.  Hypertrophic cardiomyopathy. , 1987, Disease-a-month : DM.

[683]  J. Hollifield.  Magnesium depletion, diuretics, and arrhythmias. , 1987, American Journal of Medicine.

[684]  P. Armstrong,et al.  Serum magnesium and potassium in acute myocardial infarction. Influence on ventricular arrhythmias. , 1987, Archives of internal medicine.

[685]  R. D'Agostino,et al.  Sudden death risk in overt coronary heart disease: the Framingham Study. , 1987, American heart journal.

[686]  T. Lundman,et al.  Unexpected death in patients suffering from eating disorders , 1986, Acta psychiatrica Scandinavica.

[687]  A. Heagerty,et al.  Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality. , 1986, International journal of cardiology.

[688]  G. A. West,et al.  Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity. , 1986, Circulation.

[689]  B. Deal,et al.  Ventricular tachycardia in a young population without overt heart disease. , 1986, Circulation.

[690]  J. Hollifield,et al.  Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium, and ventricular ectopy. , 1986, The American journal of medicine.

[691]  V. Backer,et al.  INTRAVENOUS MAGNESIUM IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.

[692]  M. S. Freed,et al.  Ventricular tachycardia in acute rheumatic fever. , 1985, Archives of internal medicine.

[693]  W. Kannel,et al.  Sudden death: lessons from subsets in population studies. , 1985, Journal of the American College of Cardiology.

[694]  C. Oakley,et al.  Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. , 1985, British heart journal.

[695]  J. Nordrehaug,et al.  Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction. , 1985, Circulation.

[696]  L. Horowitz,et al.  Use of intravenous verapamil for ventricular tachycardia. , 1984, The American journal of cardiology.

[697]  M. Josephson,et al.  Repetitive, monomorphic ventricular tachycardia: clinical and electrophysiologic characteristics in patients with and patients without organic heart disease. , 1984, The American journal of cardiology.

[698]  W. Stevenson,et al.  Cardiac involvement in myotonic muscular dystrophy (Steinert's disease): a prospective study of 25 patients. , 1984, The American journal of cardiology.

[699]  R. Solomon.  Ventricular Arrhythmias in Patients with Myocardial Infarction and Ischaemia , 1984, Drugs.

[700]  W. Mckenna,et al.  Amiodarone for long-term management of patients with hypertrophic cardiomyopathy. , 1984, The American journal of cardiology.

[701]  N. Hardin,et al.  Iatrogenic cardiac herniation: post mortem case. , 1984, The Journal of trauma.

[702]  A. Garson,et al.  Surgical treatment of ventricular tachycardia in infants. , 1984, The New England journal of medicine.

[703]  E. Williams.  A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs , 1984 .

[704]  A. Keren,et al.  Magnesium therapy for torsades de pointes. , 1984, The American journal of cardiology.

[705]  D. Packer,et al.  Ventricular tachycardia induced by atrial stimulation in patients without symptomatic cardiac disease. , 1983, The American journal of cardiology.

[706]  G. von der Lippe,et al.  Hypokalaemia and ventricular fibrillation in acute myocardial infarction. , 1983, British heart journal.

[707]  M. Josephson,et al.  Right ventricular tachycardia: clinical and electrophysiologic characteristics. , 1983, Circulation.

[708]  A. Camm,et al.  Effect of the Antiarrhythmic Agent Flecainide Acetate on Acute and Chronic Pacing Thresholds , 1983, Pacing and clinical electrophysiology : PACE.

[709]  L. Cobb,et al.  Hypokalemia after resuscitation from out-of-hospital ventricular fibrillation. , 1982, JAMA.

[710]  E. Prystowsky,et al.  Clinical and electrophysiologic findings in patients with repetitive monomorphic ventricular tachycardia and otherwise normal electrocardiogram. , 1982, The American journal of cardiology.

[711]  W. Roberts,et al.  Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. , 1982, Circulation.

[712]  R. DeSilva.  CENTRAL NERVOUS SYSTEM RISK FACTORS FOR SUDDEN CARDIAC DEATH * , 1982, Journal of the South Carolina Medical Association.

[713]  J. Fleg,et al.  Cardiac Arrhythmias in a Healthy Elderly Population: Detection by 24-hour Ambulatory Electrocardiography , 1982 .

[714]  S. Laniado,et al.  Response of recurrent sustained ventricular tachycardia to verapamil. , 1981, British heart journal.

[715]  J. Goldberg,et al.  Ventricular Premature Complexes and Sudden Death After Myocardial Infarction , 1981, Circulation.

[716]  N. El-Sherif,et al.  Canine Ventricular Arrhythmias in the Late Myocardial Infarction Period , 1981, Circulation research.

[717]  W. Dassen,et al.  Comprehensive Clinical Electrophysiologic Studies in the Investigation of Documented or Suspected Tachyeardias: Time, Staff, Problems and Costs , 1980, Circulation.

[718]  J. Perloff,et al.  Cardiac conduction in the Kearns-Sayre syndrome (a neuromuscular disorder associated with progressive external ophthalmoplegia and pigmentary retinopathy). Report of 2 cases and review of 17 published cases. , 1979, The American journal of cardiology.

[719]  A. B. Weisse,et al.  Arrhythmias and the "Holiday Heart": alcohol-associated cardiac rhythm disorders. , 1978, American heart journal.

[720]  A. Dyer,et al.  Alcohol Consumption, Cardiovascular Risk Factors, and Mortality in Two Chicago Epidemiologic Studies , 1977, Circulation.

[721]  J. Goldberg,et al.  Ventricular premature beats and mortality after myocardial infarction. , 1977, The New England journal of medicine.

[722]  M. Brodsky,et al.  Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease. , 1977, The American journal of cardiology.

[723]  T. D. Sellers,et al.  Digitalis in the Pre-excitation Syndrome: Analysis during Atrial Fibrillation , 1977, Circulation.

[724]  J. Freed,et al.  Magnesium deficiency and cardiac disorders. , 1975, The American journal of medicine.

[725]  H. Wellens,et al.  Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients. , 1974, The New England journal of medicine.

[726]  A. S. Mary,et al.  Ventricular tachycardia in a patient with toxoplasmosis. , 1973, British heart journal.

[727]  B. Surawicz,et al.  Ectopic beats and atrioventricular conduction disturbances. In patients with hypopotassemia. , 1967, Archives of internal medicine.

[728]  L. Kuller,et al.  AN EPIDEMIOLOGICAL STUDY OF SUDDEN AND UNEXPECTED DEATHS IN ADULTS , 1967, Medicine.

[729]  L. Kuller,et al.  Epidemiological Study of Sudden and Unexpected Deaths due to Arteriosclerotic Heart Disease , 1966, Circulation.

[730]  C. Fisch,et al.  OBSERVATIONS ON THE CARDIOVASCULAR INVOLVEMENT IN FRIEDREICH'S ATAXIA. , 1963, American heart journal.

[731]  S. Duval,et al.  Impact of Implantable Cardioverter-Defibrillators on Waitlist Mortality Among Patients Awaiting Heart Transplantation: An UNOS/OPTN Analysis. , 2017, JACC. Clinical electrophysiology.

[732]  D. Driscoll,et al.  Sudden cardiac death and late arrhythmias after the Fontan operation , 2017, Congenital heart disease.

[733]  G. Fonarow,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Circulation.

[734]  H. Calkins,et al.  Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers. , 2016, Heart rhythm.

[735]  L. Shaw,et al.  ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[736]  F. Fynn-Thompson,et al.  Left thoracoscopic sympathectomy for cardiac denervation in patients with life-threatening ventricular arrhythmias. , 2014, The Journal of thoracic and cardiovascular surgery.

[737]  Yingying Tang,et al.  Molecular diagnostics of cardiovascular diseases in sudden unexplained death. , 2014, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[738]  RobertSchönbauer,et al.  Outcomes in Catheter Ablation of Ventricular Tachycardia in Dilated Nonischemic Cardiomyopathy Compared With Ischemic Cardiomyopathy , 2014 .

[739]  E. Topol,et al.  Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. , 2014, The American journal of medicine.

[740]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[741]  L. Eckardt,et al.  Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study. , 2013, Heart rhythm.

[742]  M. Nishizaki,et al.  Clinical implications of an implantable cardioverter-defibrillator in patients with vasospastic angina and lethal ventricular arrhythmia. , 2012, Journal of the American College of Cardiology.

[743]  K. Mahaffey,et al.  ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation , 2012 .

[744]  R. Friedman,et al.  Use of a Cardioselective Beta-Blocker for Pediatric Patients With Prolonged QT Syndrome , 2010, Pediatric Cardiology.

[745]  A. Moss,et al.  Examination of the Effect of Implantable Cardioverter-Defibrillators on Health-Related Quality of Life , 2009, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[746]  S. Priori,et al.  Genetic testing for long QT syndrome. , 2008, Technology Evaluation Center Assessment Program. Executive summary.

[747]  D. Corrado,et al.  Idiopathic Right Ventricular Outflow Tract Tachycardia , 2007 .

[748]  P. Insulander,et al.  Surgery for ventricular tachycardia in patients undergoing left ventricular reconstruction by the Dor procedure. , 2006, The Annals of thoracic surgery.

[749]  E. Nanba,et al.  [Myotonic dystrophy]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[750]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[751]  H. Crijns,et al.  Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? , 2004, Journal of Molecular Medicine.

[752]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.

[753]  J. Brugada,et al.  Electrical storm in Brugada syndrome successfully treated using isoprenaline. , 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[754]  Panos Vardas,et al.  Update of the guidelines on sudden cardiac death of the European Society of Cardiology. , 2003, European heart journal.

[755]  Ming-Hui Chen,et al.  Incidence and prognosis of syncope , 2003 .

[756]  J. Coromilas,et al.  Effect of (cid:1) -Blocking Therapy on Outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT) , 2002 .

[757]  Javid A. Malik,et al.  Transient complete heart block complicating acute rheumatic fever. , 2002, Indian heart journal.

[758]  B. Gersh,et al.  Functional and prognostic significance of exercise-induced ventricular arrhythmias in patients with suspected coronary artery disease. , 2002, The American journal of cardiology.

[759]  M. Munclinger,et al.  Follow-up of patients with arrhythmogenic right ventricular cardiomyopathy dysplasia. , 2000, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[760]  P. Touboul,et al.  Arrhythmic cardiac arrest due to isolated coronary artery spasm: long-term outcome of seven resuscitated patients. , 1998, Journal of the American College of Cardiology.

[761]  A. Camm,et al.  Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial). , 1998, European heart journal.

[762]  S. Saksena,et al.  Implantable Defibrillator Therapy for the Elderly. , 1998, The American journal of geriatric cardiology.

[763]  M. Lenk,et al.  Detection of early anthracycline-induced cardiotoxicity in childhood cancer with dobutamine stress echocardiography. , 1998, The Turkish journal of pediatrics.

[764]  L. Ekström,et al.  Lidocaine in out-of-hospital ventricular fibrillation. Does it improve survival? , 1997, Resuscitation.

[765]  Facc Cardiac.  Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias , 1997 .

[766]  R. Winkle,et al.  Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group. , 1996, Journal of the American College of Cardiology.

[767]  B. McCrindle,et al.  Clinical spectrum, therapeutic management, and follow-up of ventricular tachycardia in infants and young children. , 1996, American heart journal.

[768]  M. Keating,et al.  A new form of long QT syndrome associated with syndactyly. , 1995, Journal of the American College of Cardiology.

[769]  K. Gowrishankar,et al.  Varied manifestations of viral myocarditis , 1994, Indian journal of pediatrics.

[770]  I. Maia,et al.  [Repetitive monomorphic ventricular tachycardia]. , 1994, Arquivos brasileiros de cardiologia.

[771]  W. Stevenson,et al.  Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. , 1993, Journal of the American College of Cardiology.

[772]  A. Castellanos,et al.  Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm. , 1992, The New England journal of medicine.

[773]  C. Lau,et al.  Incessant automatic ventricular tachycardia complicating acute coxsackie B myocarditis. , 1992, Cardiology.

[774]  F. Marchlinski,et al.  Dissociation of termination and prevention of inducibility of sustained ventricular tachycardia with infusion of procainamide: evidence for distinct mechanisms. , 1992, Journal of the American College of Cardiology.

[775]  J. Mason,et al.  Electrophysiologic testing in patients with the long QT syndrome. , 1985, Circulation.

[776]  E. Epstein,et al.  Myocardial ultrastructure and the development of atrioventricular block in Kearns-Sayre syndrome. , 1981, Circulation.

[777]  H. Wellens,et al.  The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex. , 1978, The American journal of medicine.

[778]  E. Lichstein,et al.  Hypomagnesemia and refractory cardiac arrhythmia in a nondigitalized patient. , 1973, The American journal of cardiology.

[779]  T. N. James,et al.  Observations on the cardiovascular involvement, including the cardiac conduction system, in progressive muscular dystrophy. , 1962, American heart journal.

[780]  S. Narayan,et al.  Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study. , 2009, Journal of the American College of Cardiology.